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ABSTRACT
A NOVEL AND RAPID STAPHYLOCOCCUS AUREUS BACTERIAL
IDENTIFICATION METHOD UTILIZING IMMUNOMAGNETIC BEADS AND
SINGLE CELL LASER-LIGHT SCATTERING
By
Kaylagh Hollen
Staphylococcus aureus (Gram-positive cocci) is the most commonly isolated
human associated bacterial pathogen. It plays an important role in skin and soft-tissue
infections, pneumonia, endocarditis, osteomyelitis, foreign-body infections, and sepsis. S.
aureus diagnosis and treatment includes identification, susceptibility testing, screening
for methicillin resistance, and glycopeptide resistance, which requires a minimum of 2448 hours depending upon the method. With this in mind, previous studies suggest that
faster pathogen identification has been linked to improved patient outcomes. Improved
patient outcomes including a reduction in hospitalization time, decreased risk of
nosocomial infections, and decreased in medical costs. The impact of faster identification
on patient outcome has led us to develop an alternative method of S. aureus identification
via ImmunoMagnetic Separation and laser-light scattering identification technology.
With this method, we hypothesized that anti-Protein A conjugated to magnetic
DynaBeads (also referred to as, anti-Protein A DynaBeads) could bind to surface Protein
A on S. aureus from swab sample and facilitate their isolation upon exposure to a
magnetic field within a 4-8 hour procedure. S. aureus cells isolated by IMS would then
be accurately identified using laser-light scattering technology in less than 5 minutes.
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Prior to the development of these methods, MIT identification accuracy analysis
was conducted and displayed that both laboratory and clinical Staphylococcus species
strains identified at a rate greater than 95% and negative control strains identified at a rate
less than 1%. After confirming MIT accuracy, we developed IMS capture methods in
order to bypass the lengthy step of growing bacteria on agar plates. We then evaluated
these methods for specificity and capture efficiency for S. aureus. Our S. aureus IMS
methods displayed statistically significant (P < 0.001) specificity for S. aureus and
capture efficiency greater than 80%. After IMS capture, an enrichment step was
developed prior to laser-light identification, in order to obtain the necessary number of
bacteria cells within a sample for proper laser-light scattering identification (1,000
bacteria cells per milliliter). Optimal conditions for IMS capture, enrichment, and laserlight identification methods were established and utilized to isolate and identify S. aureus
from both pure and mixed cultures in 4-8 hours. With these methods we were able to
successfully capture and identify S. aureus in less than 8 hours. In typical wound
infections, specimens are collected from these types of infection sites on sterile swabs.
Furthermore, we utilized our methods on swab collected specimens, where we
demonstrated that we could successfully capture and identify S. aureus in less than 8
hours. The combination of IMS and laser-light identification gives a rapid and accurate
identification in less than 8 hours, which is significantly less than traditional culture
based identification methods.
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW

Staphylococcus aureus
Staphylococcus aureus is the most commonly isolated human associated bacterial
pathogen. It plays an important role in skin and soft-tissue infections, pneumonia,
endocarditis, osteomyelitis, foreign-body infections, and sepsis 21,69. S. aureus is
characterized as a large Gram-positive coccus (1 µm in diameter) that grows in grape-like
clusters 21. Its colonies are pigmented yellow or golden but some colonies may also be
white. Unlike many other species of the Staphylococcus genus, S. aureus secretes an
enzyme, coagulase, which clots plasma. S. aureus is best distinguished from other
Staphylococcus species by the presence of coagulase and mannitol fermentation. S.
aureus is one of the most resilient of the non-spore forming bacteria and
characteristically survives on dry, inanimate objects for up to 7 days to 7 months 47,51.
Humans are the main reservoir for S. aureus. Approximately 30% of healthy
individuals are colonized by S. aureus and up to 90% of people are colonized during
one’s lifetime. It is believed that 20% are persistent carriers, 60% are intermittent
carriers, and 20% are non-carriers who rarely harbor the bacteria 32. S. aureus commonly
colonizes in the nares of humans; however, it can also be found on the skin, oropharynx,
vagina, and in feces. Due to its ability to produce lipases and glycerol ester hydrolases, S.
aureus has the ability to grow at high salt and lipid concentrations enabling it to colonize
the skin. In addition to human colonization, it can also survive on domestic animals,
livestock, and inanimate surfaces and objects such as clothing, bedding, and other hard
surfaces 21,69.
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S. aureus as a pathogen
S. aureus is the most common pus producing (pyogenic) bacteria that can cause
human disease. S. aureus can generate a wide range of infections including: abscesses at
any site of the body, pneumonia, osteomyelitis, endocarditis, toxic shock syndrome
(TSS), Staphylococcal scalded skin syndrome (SSSS), and Staphylococcal food
poisoning (SFP) 21,69. S. aureus is spread from person to person, usually through direct
contact or upper respiratory aerosols during bacterial infections. S. aureus generally does
not penetrate into deep tissues unless there is damage to the skin. Skin damage such as
burns, cuts, lacerations, insect bites, or surgical intervention may result in the entry of S.
aureus into the mucosal membranes of the host. If S. aureus is present in large
concentrations, there is a potential for spontaneous entry and infection. Poor hygiene and
prolonged skin moisture may increase the growth rate of S. aureus and lead to
spontaneous infection. It is not known if S. aureus spontaneously penetrates the skin or if
it enters through damaged skin 69. If S. aureus does penetrate the skin and enter into deep
tissues, there are several factors that could contribute to its survival including: the
concentration of entering bacteria, the site of entry, the speed of the hosts immune
response, and the immune system strength of the host 69. S. aureus infections are usually
stopped when the initial inoculum is small and an individual’s immune system is
competent. If an infection does occur, the damage most commonly results in abscesses.
Abscesses are collections of pus. Abscesses in the skin are referred to as boils or
furuncles and multiple interconnected abscesses are called carbuncles 69.
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Methicillin-resistant S. aureus (MRSA)
In 1961, soon after the introduction of the antibiotic methicillin, the first βlactamase-resistant penicillin strains of S. aureus were also found to be resistant to
methicillin 21,46. From the 1960s to the early 1970s, methicillin-resistant S. aureus
(MRSA) infections were largely found in hospital-acquired settings (HA-MRSA). HAMRSA strains are largely isolated from immunocompromised individuals or individuals
exposed to health care settings. HA-MRSA strains tend to cause pneumonia, bacteremia,
and invasive infections 21. Today, MRSA causes the majority of nosocomial infections
worldwide 36. HA-MRSA infections are defined as a patient whose MRSA isolate was
cultured more than 48 hours after admission and who had a history of hospitalization,
surgery, dialysis, or residence in a long-term healthcare facility within 6 months prior to
the culture date, or who had an indwelling intravenous line, catheter, or any other
percutaneous medical device present at the time the culture was taken 56. HA-MRSA
carry a large Staphylococcal chromosomal cassette (SCC) mec which contains the
signature mecA gene (type I, II, or III). MecA is a 2.1 kb gene that encodes for a
transpeptidase, which results in 78-kDa cell-wall protein called Penicillin Binding Protein
2a (PBP2a). PBP2a mediates continued peptidoglycan synthesis even when in the
presence of β-lactams. β-lactam antibiotics bind to PBPs that are present on the surface of
S. aureus, however PBP2a has evolved to have low binding affinity for these antibiotics,
resulting in the continued growth of these strains 23,69. HA-MRSA mecA gene types vary
in size and function, SCCmec I (34.3 kb) results in β-lactam resistance while, SCCmec II
(53.0 kb) and SCCmec III (66.9 kb) result in resistance to multiple classes of antibiotics
23

. HA-MRSA are often resistant to many classes of non-β-lactam antibiotics and rarely
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carry the gene for Panton-Valentine leukocidin (PVL), which functions in neutrophil lysis
21

.
Prior to the 1990s, MRSA infections were confined largely to patients and within

health care settings; however, the rate of community-acquired MRSA (CA-MRSA)
infections has increased immensely. A study conducted in 2005 found that greater than
80% of all MRSA infections were attributed to CA-MRSA strains, as opposed to HAMRSA strains 54. CA-MRSA infections are defined as strains isolated in an outpatient
setting, or isolated from patients within 48 hours of hospital admission. These patients
must have no medical history of MRSA infection or colonization, and no medical history
in the past year of either hospitalization, admission to a nursing home, or dialysis 56.
These strains tend to be more virulent than HA-MRSA strains and CA-MRSA has begun
to replace HA-MRSA in health care settings 44,50. It has been found that CA-MRSA
patients often lacked risk factors known for patients with HA-MRSA infections. Those
risk factors include, recent hospitalization, dialysis, nursing-home residence, or other comorbid conditions 44. CA-MRSA strains carry smaller SCCmec elements (type IV or V)
compared to the HA-MRSA (type I, II, or III). The CA-MRSA SCCmec types vary in
size which are, SCCmec IV (20.9-24.3 kb) and SCCmec V (28 kb). They also carry the
mecA gene and are believed to be more genetically mobile. In addition, they also are
resistant to fewer non-β-lactam antibiotics than HA-MRSA and tend to carry the gene for
PVL. Groups that are at risk for CA-MRSA infections in the United States include:
neonates, children beyond the neonatal period (daycare centers), athletes, household
contacts of MRSA patients, emergency department patients, indigenous populations,
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detainees in jail or prison, cystic fibrosis patients, military personnel, HIV patients, and
veterinarians and livestock handlers 21.
S. aureus virulence
In a highly regulated manner, under appropriate conditions, S. aureus produces
numerous virulence factors such as exotoxins and cell surface proteins. These virulence
factors result in increased pathogenicity and survival within host cells 4,69. S. aureus has
the ability to colonize the skin and mucosal surfaces by way of microbial surface
components recognizing adhesive matrix molecules (MSCRAMMs), which enable S.
aureus to bind to a wide variety of host surface proteins 69. The most prevalent group of
cell wall-anchored proteins of S. aureus are the MSCRAMMs. MSCRAMMs are defined
by their tandemly linked IgG-like folded domains and function in many diverse ways 28.
Their functions include colonization of host tissues and the evasion of host defenses 28.
Notable MSCRAMMs include: fibronectin-binding proteins, collagen binding proteins,
and fibrinogen binding proteins. Fibronectin-binding proteins (FnbpA and FnbpB) are
found on the surface of S. aureus and allow the bacteria to invade epithelial and
endothelial cells. Fnbps also attach to exposed fibronectin in wounds leading to deep
tissue infections 69. Collagen binding proteins (CBPs) function by binding collagen-rich
tissues and prevent the classical pathway of complement activation 28. Clumping factors
A and B function in fibrinogen binding and result in clot formation and endocarditis.
Clumping factor A function in adhesion to immobilized fibrinogen resulting in immune
evasion by binding soluble fibrinogen. Clumping factor B function in the adhesions to
desquamated epithelial cells and result in nasal colonization 28. In addition to
MSCRAMMs, other cell wall-anchored (CWA) proteins include those from the near iron
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transporter (NEAT) motif family, the G5-E repeat family, the Three-helical bundle
(Protein A), and structurally uncharacterized proteins.
Protein A, regulated by the spa gene, is expressed on the surface of nearly all S.
aureus strains and occupies approximately 7% of the S. aureus cell surface 30. Protein A
is involved in the avoidance of phagocytosis of the host’s defense system. More
specifically, Protein A binds the Fc regions of IgG thus preventing opsonization and
subsequent phagocytosis 21. Protein A is expressed in both the secreted and membrane
bound form so it can be released into the environment surrounding bacterial growth
where it can bind free IgG antibodies 21,69. This protein possesses two Ig-binding
activities: each of its five domains can bind either the Fc or Fab regions of IgG
antibodies. The Fc region naturally functions in the binding of antigens for the
complement system and the Fab region is responsible for antigen recognition 7. More
specifically, Protein A binds the Fc site via the CH2 and CH3 interfaces and can also
bind a variable region of the Fab region of the IgG heavy chain 33.
The result of Protein A binding IgGs is the activation of tumor necrosis factor
within the host and this can induce inflammation after triggering B-cell proliferation 21.
Studies display that S. aureus strains lacking Protein A are phagocytized more efficiently
in vitro and have overall decreased virulence in murine models of septic arthritis and
pneumonia 59. Protein A is encoded by the gene Spa. Spa, a growth stage dependent
gene, is upregulated during the exponential growth phase and is down-regulated during
the post-exponential phase of growth 59. There are numerous regulatory elements that
have been shown to directly and indirectly regulate spa gene expression including Agr
(RNAIII), Arl, MgrA, SarU, SarA, SarS, SarT, and XdrA. Spa regulation is not only
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associated with Protein A but many other networks that regulate a multitude of virulence
factors in S. aureus, such as, exotoxins and β-lactam resistance 59.
S. aureus secretes many enzymes and toxins that function in the battle with host
immune cells 69. One of those members is catalase, which functions by converting
hydrogen peroxide to water, counteracting neutrophils’ ability to kill bacteria by the
production of oxygen free radicals 69. Another S. aureus enzyme, coagulase, converts
fibrinogen to fibrin preventing phagocytosis. In addition to enzymatic immune system
evasion, secreted toxins are also utilized to aid in immune system avoidance by S. aureus.
S. aureus possesses a group of toxins that targets cytoplasmic membranes of its
host. These membrane-damaging toxins include four hemolysins (α, β, γ, and δ) and
leukocidins. These toxins penetrate membranes causing the formation of pores within the
host’s membrane. Two types of the membrane-damaging toxins are receptor-mediated
toxins and non-receptor mediated toxins. Receptor mediated toxins show higher cell
specificity than toxins not mediated by receptors. Receptor mediated toxins often play a
role in lysis of red (hemolysin) and white blood cells (leukocidin) 65. Specific receptormediated toxins include the α- and γ-toxins, PVL, and leukocidins LukED and LukAB.
Hemolysin, or α-toxin, is lytic to red blood cells and multiple leukocytes, but not to
neutrophils. The α-toxin is a secreted β-barrel pore-forming toxin that functions by
binding to ADAM10 receptors of host cells resulting in apoptosis of those cells 28,65. The
γ-toxin plays a role in the pathogenesis of TSS 63. PVL is a two-component pore-forming
protein that can lyse neutrophils. PVL can be easily spread strain to strain by horizontal
gene transfer via bacteriophages, which drastically increases the virulence of S. aureus
strains. PVL is closely linked to CA-MRSA strains and it is estimated that 60-100% of
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CA-MRSA strains carry the PVL genes 21. S. aureus also possesses leukocidins, which
function in neutrophil killing and escape, resulting in the promotion of its survival within
the host. LukAB is a leukocidin that contributes to neutrophil killing by both external and
internal interactions. LukAB can cause damage to neutrophils by directly binding to its
cell surface. S. aureus can also cause damage to neutrophils from within the immune cell
by secreting LukAB 61. LukED is a major S. aureus virulence factor involved in the
promotion of disease progression during septic infection 3. LukED is produced during the
course of human infection and has been linked to S. aureus associated impetigo and
diarrhea 3,34
In addition to receptor-mediated hemolysins and leukocidins, there are also toxins
that are not regulated by receptors. These toxins are often less specific but still contribute
to host cell membrane damage. The δ-toxin, part of a family of secreted peptides called
the phenol-soluble modulins (PSMs), functions in non-specific cytolytic activity and the
triggering of inflammatory responses 52. The role of β-toxin is unclear; however, it is
believed to play an important role in biofilm formation, especially during endocarditis
infections 69. In addition to membrane-damaging toxin, S. aureus also possesses
enterotoxins, which interfere with receptor function. Enterotoxins are secreted toxins (2030 kDa) that interfere with intestine function causing diarrhea and vomiting 40. These
enterotoxins are also considered to be superantigens. Superantigens trigger T cell
activation and proliferation without the need for antigen processing by allowing nonspecific interaction with T cell receptors 65. The mechanism for cytokine release for these
toxins is not well known but the resulting conclusion is cell death by apoptosis for host
immune cells 53. The most prevalent enterotoxins that S. aureus possesses are

8

Staphylococcal enterotoxin B (SEB), Staphylococcal enterotoxin C (SEC), and toxic
shock syndrome toxin (TSST). Superantigen SEB causes cellular cytotoxicity by
inducing inflammatory cytokine release with the potential to result in septic shock 53.
Superantigen SEC has been linked to endocarditis, sepsis, and kidney damage when the
SEC gene is found in CA-MRSA strains 75. TSST, the superantigen that causes TSS
stimulates the release of IL-1, IL-2, TNF-α, and other cytokines which function as
signaling molecules to mediate and regulate immunity and inflammation 63. In addition to
the previously mentioned toxins, S. aureus is also equipped with other enzymes and
toxins that function in the interference with the host’s immune system. Overall, S. aureus
virulence and survival revolves around its ability to both damaging host cells and avoid
rapid killing by host neutrophils.
S. aureus diagnosis and treatment
Recommendations for S. aureus diagnosis and treatment include identification,
susceptibility testing, screening for MRSA, and glycopeptide resistance. Identification of
S. aureus is traditionally achieved by coagulase tests or latex agglutination tests;
however, identification can also be achieved by detection of Protein A production and
heat-stable nucleases 8. Coagulase tests can be conducted in a test tube or on a slide. Test
tube coagulase tests are used to identify the presence of bound or free coagulase within a
sample. Slide coagulase tests are used to identify the presence of cell-bound clumping
factor. Slide agglutination tests are very rapid but up to 15% of S. aureus strains are
negative, so slide tests need to be confirmed with tube agglutination tests. 83
Staphylococcus schleiferi, Staphylococcus lugdunensis, and Staphylococcus intermedius
may give positive results in coagulase and clumping factor tests 89. Latex agglutination
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tests detect for the presence of Protein A and/or clumping factor, and various surface
antigens. There are additional biochemical test kits and automated instruments that are
used to identify S. aureus; however, these methods are generally slower and more
expensive than traditional agar-based identification methods. In contrast, other
biochemical methods, including Staphychrom II and CHROMagar have been found to
work better than tube coagulase identification tests 9,27. Staphychrom II is a two hour
chromogenic test that uses human prothrombin and protease inhibitors, as well as a color
indicator (yellow) to identify S. aureus 27. CHROMagar identifies S. aureus by growing
the isolated strain on the medium. Colonies that appear pink are identified as S. aureus 9.
In addition to traditional identification tests, S. aureus can be identified by
deoxyribonuclease (DNase) tests and molecular tests. Diagnostic laboratories use of
molecular tests for S. aureus identification is unlikely unless there is a high suspicion of a
MRSA infection. Molecular tests are often conducted for confirmation or to determine
susceptibility to methicillin/oxacillin; the combination of S. aureus identification and
susceptibility reading allows for rapid identification of MRSA isolates 8. The majority of
molecular based tests are PCR based and have species-specific targets. For MRSA
strains, traditional targets are nuclease (nuc), coagulase (coa), Protein A (spa), femA,
femB, Sa442, 16s rRNA and other surface-associated fibrinogen-binding protein genes
31,58,86

.
For S. aureus skin infections, incision and drainage remains the primary therapy.

In addition to incision and drainage, antimicrobial coverage for MRSA may also be
necessary 10. S. aureus infections can be treated with antibiotics that target pathways
essential for survival including: cell-wall synthesis, folic acid metabolism, and bacterial
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protein synthesis. S. aureus tends to be resistant to penicillin and semi-sensitive to
semisynthetic penicillins, such as nafcillin (methicillin-sensitive S. aureus, or MSSA).
When determining the course of treatment, antibiotic administration should be guided by
the susceptibility profile of the strain and the type of infection. The Centers for Disease
Control and Prevention (CDC) recommends clindamycin to treat serious S. aureus
infections; however, a D-zone test should be performed in order to identify inducible
clindamycin resistance in erythromycin-resistant S. aureus strains 11. D-zone tests are
performed by disk diffusion by placing an erythromycin disk (15 µg) in proximity to a
clindamycin disk (2 µg) on an agar plate that has been inoculated with a Staphylococcus
species and incubated overnight. A flattening of the zone of inhibition around the
clindamycin disk proximal to the erythromycin disk (producing a D shaped zone of
inhibition) is considered a positive result. This indicates that erythromycin has induced
clindamycin resistance 2. Tetracyclines, such as doxycycline and minocycline are also
used to treat S. aureus skin infections, but are not recommended during pregnancy or for
children under the age of eight. Rifampin is also used to treat S. aureus but only in
combination with other agents. Linezolid can be utilized to treat complex skin infections,
including MRSA; however, consulting an infectious disease specialist is suggested. When
treating MRSA strains, these strains are resistant to all available β-lactam antibiotics
(penicillins and cephalosporins). Fluoroquinolones and macrolides are also not optimal
treatments for MRSA skin and soft tissue infections due to resistance or the potential of
resistance development 11.
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Other microbes utilized in this study
Many infections can be polymicrobial, and it is rare to find pathogenic organisms
isolated from the human body in pure culture from the initial infection site. Negative
control organisms that were used in this project were carefully picked with the intention
of mimicking real-life conditions of mixed bacterial samples. Both skin infections and
other potential contaminants were chosen in order to represent a realistic mixed sample.
The following organisms were chosen in order to recapitulate a skin sample that might
contain multiple bacteria: Staphylococcus epidermidis, Streptococcus pyogenes, and
Micrococcus luteus, and Enterococcus faecalis. Staphylococcus epidermidis is a Grampositive cocci (0.8-1 µm) that generally appears in single cells or small clusters. S.
epidermidis is found on the skin of most people but rarely causes disease in health
individuals 21. Although S. epidermidis is a commensal organism, it can be considered an
opportunistic pathogen causing infections via catheters and medical devices 66. S.
pyogenes, a human pathogen, is a Gram-positive cocci (0.6-1 µm) that colonizes the
nasopharynx and the skin at portals of entry or as asymptomatic carriers 60. Streptococci
species are common on the skin and in the upper respiratory system. Group A
Streptococcus can be classified by their beta-hemolytic behavior on blood agar.
Streptococci are transmitted by contact between humans who carry the organism or have
an associated disease. When disease occurs, the organism grows on mucous membranes,
in skin, or in deep tissues. M. luteus is a Gram-positive cocci (0.6-1 µm) that is a normal
inhabitant of human skin. This microbe rarely causes infections; however, M. luteus has
been associated with septic arthritis, meningitis, and endocarditis in patients with immune
suppressive conditions 76. E. faecalis is a Gram-positive cocci (0.5-1 µm) that grows in
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pairs or chains and ferments carbon sources that produce lactic acid 60. Enterococci are
commensal organisms that survive in intestinal and vaginal tracts and the oral cavity 45.
E. faecalis causes 80-90% of infection of Enterococci infections and is the fourth leading
cause of hospital-acquired infections and the third leading cause of bacteremia in the
United States 24,45. Enterococci are frequently isolated with Staphylococci in diabetic soft
tissue infections, which is the reason for the use of this species as a negative control 39.
Other potential contaminants that were utilized to recapitulate samples that may
be found in a Staphylococcal food-poisoning sample were: Escherichia coli,
Enterobacter aerogenes, and Listeria monocytogenes. Bacillus subtilis was also utilized
as a potential environmental contaminant. E. coli is a flagellated Gram-negative rod (2
µm in length) found living in the intestines of people and animals. Pathogenic E. coli
strains can cause urinary tract infections, respiratory illness and pneumonia, and other
gastrointestinal illnesses. E. coli is generally transmitted through contaminated water or
food, or via direct contact with animals or humans 13. E. aerogenes is a Gram-negative
(1.2-3.0 µm in length) flagellated rod shaped organism found in soil, water, dairy
products, and in the intestines of humans and animals. E. faecalis is a Gram-positive
cocci (0.5-1 µm) that is an opportunistic pathogen that generally infects
immunocompromised individuals and causes urinary tract infections, endocarditis,
abdominal infections, and septic arthritis 81. L. monocytogenes is a Gram-positive rod
shaped (2 µm) bacteria with a temperature regulated flagella 35. L. monocytogenes causes
serious infections by eating food contaminated with this microbe. Symptoms of listeriosis
include fever and muscle aches, sometimes diarrhea and other gastrointestinal symptoms
12

. B. subtilis is an endospore forming Gram-positive rod (3 µm in length) that is typically
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found in soil, dust, water, and in the air; however, its primary reservoir is soil 80. Bacillus
species are organisms that are common residents of dirt, soil, and dust and therefore
could be co-isolated with S. aureus in samples contaminated with dirt, soil, and/or dust.

Table 1. Staphylococcus aureus Protein A protein BLAST results. S. aureus Protein A protein
sequence was obtained using NCBI a BLAST search was conducted, excluding S. aureus (taxid:
1280), synthetic constructs (taxid: 32630), plasmids (taxid: 36549), and cloning vectors (taxid:
29278) in order to determine what other organisms had a protein similar in percent identity to S.
aureus Protein A.
Max
Score

Total
Score

Query
Cover

EValue

Percent
Identity

Staphylococcus
argenteus

578

578

99%

0

95%

CDR59589.1

Protein A

Staphylococcus
schweitzeri

528

1006

99%

0

79%

CDR66424.1

Hypothetical protein

Staphylococcus
hyicus

333

333

87%

2.00E
-108

64%

WP_03964360
2.1

333

333

99%

9.00E
-108

60%

WP_03754204
7.1

328

644

97%

3.00E
-104

68%

BAS44959.1

252

252

68%

2.00E
-77

61%

WP_01916745
5.1

246

403

86%

1.00E
-76

62%

EPD49293.1

243

243

95%

8.00E
-74

50%

WP_01461269
8.1

Description
Immunoglobulin G
Binding Protein A

Peptidoglycanbinding protein LysM
Immunoglobulin G
binding Protein A

Strain

Staphylococcus
pseudintermedi
us
Staphylococcus
schleiferi

Accession

Hypothetical protein

Staphylococcus
intermedius

Immunoglobulin Gbinding Protein A
Immunoglobulin Gbinding Protein A
spa2

Staphylococcus
sp. HGB0015
Staphylococcus
pseudintermedi
us

Hypothetical protein

Staphylococcus
simulans

100

100

70%

2.00E
-20

34%

WP_05751004
9.1

BBM3XM

Staphylococcus
xylosus

90.9

320

30%

8.00E
-17

90%

AAA26599.1

PPmABPXM
precursor

Staphylococcus
carnosus

79.7

200

17%

4.00E
-13

80%

AAA61965.1

Hypothetical protein

Staphylococcus
delphini

75.9

194

84%

6.00E
-12

33%

WP_01916601
9.1

Hypothetical protein

Staphylococcus
condimenti

65.9

65.9

38%

2.00E
-08

36%

WP_04713280
8.1

Hypothetical protein

Staphylococcus
chromogenes

61.6

183

84%

4.00E
-07

31%

WP_03757738
1.1
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In addition to the previously mentioned negative controls, another subset of negative
controls utilized in this study included organisms that possess Protein A on its surface. A
protein BLAST search revealed strains with similar identity to Protein A (Table 1). The
bacterial strains found to have a percent identity greater than 30% were included in Table
1. All of the bacterial strains found to have a percent identity greater than 30% were
Staphylococci species. Of these subspecies, Staphylococcus argenteus and
Staphylococcus schweitzer have been found to be phenotypically similar to S. aureus. S.
argenteus is a non-pigmented human isolated strain that is nucA positive; while S.
schweitzer is a non-human primate strain that is nucA negative. nucA is a virulence
associated gene that codes for thermostable nuclease which plays a role in the evasion of
neutrophil extracellular traps 48,82. Although S. argenteus and S. schweitzer are the closest
known relatives of S. aureus, S. argenteus has only rarely been recovered from humans
hosts and S. schweitzer has only been recovered from a human host once to date 84.
Staphylococcus intermedius, Staphylococcus pseudointermedius, and Stpahylococcus
delphini are zoonotic strains that are typically colonizers of animals including dogs, cats,
and pigeons. These strains have typically been associated with infections caused by
animal bites but rarely colonize humans 87. Staphylococcus simulans has been isolated
from a number of animals and humans and it is also the most frequently isolated species
in association with bovine mastitis 1. Of the strains mentioned in Table 1, S. intermedius
and S. simulans were used in this study.
Rapid bacterial identification by laser-light scattering
Previous studies suggest that particle size, shape, density, and motion can all
influence how a particular particle scatters light 6,62. Bacterial cells can be thought of as
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small particles, and different
species have specific shapes, sizes,
and internal characteristics that
cause them to scatter laser-light
into distinctive patterns 6,37. To
understand how a specific species
of bacteria (like S. aureus) scatters
laser-light, many thousands of
individual cells of a species of
interest are measured in a device
developed by Micro Identification Technologies (MIT, located in San Clemente, CA;
www.micro-imaging.com). MIT has developed a system for rapid laser based microbial
detection and identification. This system measures laser-light scattering intensity as
individual microbes pass through a laser beam. The light scattering pattern is influenced
by the size, shape, external and internal optical characteristics, and the motility of the
microbe. The system can detect and differentiate the size of bacteria by measuring the
scattering light at specific angles. The system can detect and differentiate objects within a
range of sizes from 0.5 µm to more than 10 µm, which is the typical size range for most
bacteria. MIT uses an empirically based “Statistical Classification Algorithm” and a set
of pre-measured microbial scattering characteristics called Identifiers. The Identifiers are
generated from light scattering measurements of thousands of individual cells of known
microbial species or subspecies. The individual cells of specific microbes are analyzed to
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identify the measured characteristics that best differentiate that species from another, or
subspecies from another.
The MIT system feeds a stream of
light scatter measurements into the Statistical
Classification Algorithm to determine if the
measured cells are members of a specific
Identifier within the MIT database. For
example, when using the Staphylococcus spp.
Identifier, the system determines if the
sample is or is not Staphylococcus spp. The
Figure 2. Light scattering intensity as a
microbe passes though the laser beam.
The laser beam is directed toward the
reader.

system has the ability to feed the same light
scatter measurements into multiple
Identifiers simultaneously. Consequently,

the system can determine if the sample statistically matches any Identifier in the MIT
database.
The MIT system consists of five concentric arcs of photodetectors that are located
at a variety of positions along the surrounding arcs (Figure 1). Each photodetector is
positioned to view through the arcs to the center-of-curvature of the arcs 37. A solid-state
laser (660 nM) passes through the same center-of-curvature where a round bottom flask
containing a sample is positioned. As the laser passes through the sample, particles pass
through the laser beam resulting in scattered light. Photodetectors record and measure the
particles passing through the laser beam. A photon of light striking the photodetector
generates a voltage. The MIT system identifies bacteria by analyzing laser-light scatter of
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individual bacterial cells suspended in filtered water. When the laser contacts a particle
within a sample, the light both reflects off the outer surface and penetrates the body of the
particle, interacting with structural features that are specific to that particle. As a microbe
passes through the laser beam, the intensity of the scattered light increases as it gets
closer to the center of the beam and decreases as it leaves the beam. The scattered light
measured by the surrounding detectors produces a signal similar to that shown in Figure
2. A single particle that has passed through the laser beam is called an event. Figure 3
displays a typical single particle event measured as a signal (voltage) over time. More
specifically, Figure 3 displays the measured scattered light intensity for two 1.5 µm
diameter polystyrene latex spheres (Figure 3A) and two individual S. epidermidis cells
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(Figure 3B) versus time. The colored curves are the measured signal from all detectors on
one arc in the MIT system. The signal measured by the detectors is influenced by size,
shape, external and internal optical characteristics and where in the beam the particle is
located. In Figure 3, the difference between the polystyrene latex sphere and S.
epidermidis is apparent; displaying that the individual cells of S. epidermidis are not
spherically symmetrical thus resulting in variations to its scattering pattern.
By measuring hundreds of thousands of events for a specific bacterial species, the
average scattered light pattern for that particular species of interest becomes apparent
through statistical analysis. As mentioned previously, MIT has developed a Statistical
Classification Algorithm that classifies the sources of events. When bacteria cause the
events, the classification is an identification of the bacterial species. The Statistical
Classification Algorithm uses a collection of distributions called Judges that are merged
Probability Densities constructed from known pre-measured bacterial species and further
organized into entities called Identifiers. The Identifier contains Probability Densities
derived from measured events. A large number of events for each species are required in

Figure 4. Frequency-of-Occurrence Histogram for 1.5 µm diameter polystyrene spheres. This
Frequency-of-Occurrence histogram is an example for 1.5 µm diameter polystyrene spheres.
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order to ensure that the derived Probability Densities are representative of the species
involved. The same analysis may be applied to any variation in dimensions. This process
begins by defining an Observable. An Observable is one or more values calculated from
specified measured quantities. Figure 3A displays an instant in time in the left event
indicated by the gold colored vertical line labeled c This is the instant in time defined as
the time that the detector plotted in the same gold color attains a maximum for this event.
Looking closely at two detectors in Figure 3A, detector A in purple and detector B in
green at the instant marked by the vertical line c. In the left event, the two detectors have
a value of a and b at instant c. This results in Observable C(a,b). Values for each
Observable can be calculated from any other measurement. Each measurement produces
slightly different values for a and b. For the same sample (polystyrene latex spheres in
this case), slightly different Observable values measured by measuring many thousands
of different samples.

Figure 5. Frequency-of-Occurrence Histogram for Staphylococcus epidermidis. This
Frequency-of-Occurrence histogram is an example for S. epidermidis using the same
Observable and plotted on the same scale as figure 4.
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Figure 4 shows a Frequency-of-Occurrence
histogram and its contour for the Observable C(a,b).
This plots the number of times a pair of values, a
(x-axis) and b (y-axis) is measured simultaneously
by the detectors A and B for thousands of individual
spheres. When normalized so that the volume of the
histogram is 1.0, the histogram can be interpreted as
a Probability Distribution, which gives the
probability that a range of signals measured by

Figure 6. Superposition of the
contours of the Frequency-ofOccurrence Histograms in
figure 4 and 5.

detectors A and B are simultaneously measured for the sphere. Figure 3B displays two
typical events of individual cells of S. epidermidis and the same Observable illustrated in
Figure 3A. Figure 5 displays the Frequency-of-Occurrence Histogram and its contour for
S. epidermidis using the same Observable C(a,b) used to create Figure 4. The scale and
the axis limits are the same in both Figure 4 and 5. Since the scales and limits are the
same, superposing one of the contours over the other allows direct comparison of the
contours which is displayed in Figure 6. There is no overlap between the contours in
Figure 6. The Frequency-of-Occurrence histograms therefore display that the size, shape,
and location of the contours show a species dependence.
An Observable and the Probability Distribution curves generated from measurements
using that Observable for a group of species like in Figure 7 is a Judge. The Judge has
one Probability Distribution curve for each species and provides an opinion on the
identification of measurements of unknown particles. The Judge’s Opinion is the
likelihood that the cell is a particular species. The MIT system utilizes a Panel of Judges
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of the
other
bacterial species.
Thesefor
contours
are for the
same Observable
and
inFigure
order 7.
toContours
determine
identification
Opinion
that unknown
sample.
Combining
the
on the same scale as shown in figures 4 and 5. The crosshair is located at the same coordinate
in each plot,
this is a Judge.
Opinions
of individual
Judges using standard probability and statistical methods allows

for a stronger Opinion compared to that of a single Judge’s Opinion. Figure 8 displays a
series of Judges, each with different Observables and each column is a Judge consisting
of Probability Density contours derived from its Observable. Judge 1 is the Observable
F(d,e), or the values of detectors D and E when detector F is a maximum. Judge 2 is the
Observable I(g,h), or the values of detectors G and H when detector I is a maximum. The
axis limits and scale of the contours in each column are the same. This grouping of
Judges is referred to as a Panel of Judges.
A Panel of Judges does not always return a definitive identification and additional
discrimination information is still needed. The Identification process using MIT
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technology is significantly enhanced when multiple cells of the same unknown species
are measured in one sample. After measuring the first bacterial cell, the Panel of Judges
use event data to produce an identification Opinion of the unknown species.

The Opinion takes the form of a series of identification probabilities, which are combined
as the Total Identification Probability. As more cells are measured and processed, the
Total Identification Probability for the unknown species then get closer to one. If the
probability of one species is greater than 0.999 five times in a row, the species then
identifies.
23

The Panel of Judges provides quick and accurate identification of any of the species
found in the MIT database. This process is closed, meaning, if the unknown sample is not
one of the species handled by the Panel of Judges the result is unpredictable. MIT has
developed an open equivalent to the Panel of Judges called an Identifier. The Identifier
then determines whether the stream of cells is one of the species
within its database or if the result is “Unknown.” For example, a Listeria species
Identifier determines whether the stream of cells is Listeria species or if it is Unknown.
The system can simultaneously run tests for all of its Identifiers within its database, those
including Listeria species, Staphylococcus species, and S. aureus. Figure 9 displays the
simultaneous identification process utilizing two Identifiers, Listeria species and

24

Staphylococcus species. The identification tests take roughly 30 seconds to 5 minutes
with the average test being 2 minutes. In order for this test to be successfully conducted,
the system requires 10 to about 40 cells to complete depending on the rate the cells are
being measured at.
MIT sample preparation is simple, requires only a few minutes, and is the same
for all species. The supplies and apparatus that are required are: 1 inoculating loop, 1
microcentrifuge tube, 1 pipette tip, a vortex mixer, a 0.5-10 µL adjustable pipette, a MIT
sample vial, and a 1” x 1” square of parafilm. The sample preparation procedure goes as
follows: (1) remove a colony from a culture plate using a sterile loop, (2) dislodge the
bacterial colony into a microcentrifuge tube containing filtered water, (3) vigorously
agitate the microcentrifuge tube by vortexing the bacterial cells, and (4) inoculate an MIT
sample vial with approximately 1 µL of the bacterial suspension. After placing the
inoculated vial into the MIT system, click “Identify” on the MIT interface program. The
total time until identification using the MIT system totals approximately 5 minutes.
The majority of rapid bacterial identification technologies are designed to detect
the presence of genetic material or proteins from a pathogen in a patient specimen.
Detection of genomic material can be both highly sensitive and accurate, however these
methods may have limitations. Mass spectrometry and antibody-based tests that detect
pathogen proteins may require expensive machines, chemical reagents, and/or highly
skilled sample processing. Many of these tests have turnaround times as long as 18 to 48
hours. Therefore, a rapid bacterial detection system that is sensitive, accurate, and cost
effective would be advantageous. MIT technology is extremely easy to use and reduces
time, effort and cost resulting in microbial identification. The system does not rely on
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chemical processing, fluorescent tags or DNA analysis. The system eliminates elaborate
and lengthy sample preparation required in other identification techniques. The same 1
minute sample preparation is held consistent for every test run in the system. The system
requires no other additional chemicals, reagents or processing procedures, other than
dilutions. The MIT system identifies all characterized species without reconfiguration
using the same procedure. Finally, the amount of supplies and inventory required for
identification are reduced drastically compared to other identification methods. MIT has
developed their system to detect Listeria species (food-borne pathogens) from food
samples. Independent laboratories have verified that the MIT system identifies Listeria
species with greater than 90% accuracy. The MIT system was awarded Association of
Analytical Communities Research Institute Performance Tested Methods (AOAC RI
PTM) certification for its Listeria species Identifier. MIT is working to exapnd the list of
Identifiers. Staphylococcus species Identifier was utilized for this project. A S. aureus
Identifier is nearing completion, but was not available at the time of this study.
Rapid bacteria capture by ImmunoMagnetic separation (IMS)
Before this study, the MIT 1000 was being used to identify bacteria from colonies
grown on agar plates. The process of growing bacteria colonies can typically take 12-48
hours before the bacteria can be analyzed by laser-light scattering (which takes less than
5 minutes). IMS could potentially capture bacteria cells for laser-light scattering
identification within a few hours. IMS is a rapid isolation method that captures proteins
or cells using a magnetic field. Magnetic beads (10 mg/ml) are coated with antibodies
(2.8 µm, 1 mg/ml) specific for surface antigens of the desired cells 74. The two
components of the IMS method are Streptavidin coated magnetic beads (DynaBeads) and
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biotinylated S. aureus antibodies (Figure 10). The biotinylated S. aureus antibodies can
be linked to Streptavidin on the surface of the DynaBeads due to Streptavidin’s extremely
high binding affinity for biotin (Kd = 10-14 to -15 M) 5,43. When the conjugated magnetic
beads and antibodies are exposed to a mixed cell population, the magnetic beads attach to
the surface of the desired cells via antibody-antigen interaction. The desired cells can
then be separated by a strong magnetic field 74. In this study, we are utilizing a protein
found specifically on the surface of S. aureus, called Protein A, as the receptor for
antibody binding 17.

Protein A, a 42-kDa conserved surface protein of S. aureus is composed of three
different regions: the S region, which is the signal sequence processed during secretion,
five highly homologous extracellular Ig-binding domains found in tandem and designated
as E, D, A, B, and C, and a cell-wall anchoring region XM 33,42. Each of the five domains
are arranged in an anti-parallel alpha-helical bundle of approximately 58 amino acids.
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This structure is stabilized by a hydrophobic core 42. Each of these five regions has the
ability to independently bind the Fc or Fab region of IgG antibodies 22,33,42,57. The Fc
binding site has shown to involve 11 residues of helix 1 and 2 22. The Fab binding region
is located separately from the Fc binding region, the Fab binding site involves 11 residues
located on helix 2 and 3 33. Commercial antibodies against Protein A are available that
have biotin conjugated to the Fc region.
Streptavidin (52.8-kDa), isolated from Streptomyces avidinii, is a tetrameric
protein that can bind up to four d-biotin molecules with extremely high affinity 77. The
ability of streptavidin to bind biotin has led to widespread use in diagnostic assays that
require near-irreversible and specific linkage 88. Streptavidin subunits are organized as
eight-stranded, connected, anti-parallel beta sheets. This arrangement produces a
cyclically hydrogen-bonded barrel with several extended hairpin loops. One of the
extended hairpin loops is located near the carboxyl terminus where it is free to form an
extended beta sheet 88. The pairs of streptavidin barrels hydrogen bonded together form
symmetric dimers. Streptavidin forms a tetramer by pairing two dimers, the tetramer is
stabilized by Van der Waals interactions between the surfaces of the beta barrels 88.
Biotin then binds in the pockets at the ends of each of the streptavidin beta barrels. Biotin
binding involves the removal of bound water molecules that occupy the binding site.
After the removal of water, multiple interactions between biotin heteroatoms and the
binding site residues of streptavidin allow for the burial of biotin by way of a surface loop
of streptavidin 88. The strength of the streptavidin-biotin bond is the consequence of an
expansive number of interactions, which results in a near-irreversible bond that can be
exploited for diagnostic assays and other molecular uses.
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The use of IMS for bacterial isolation in food samples has been shown to be more
efficient than conventional centrifugation and other filtration methods 74. IMS has the
potential to separate S. aureus from a sample in 4-8 hours and MIT laser-light scattering
technology could complete identification in 5 minutes. It has been shown that live S.
aureus cells can be isolated using S. aureus antibodies bound to magnetic beads, which
establishes IMS technology as a method of S. aureus bacterial isolation 18.
With this technique in mind, this study aims to (1) develop IMS to magnetically
capture cells of S. aureus using anti-Protein A antibodies and (2) develop IMS to
specifically capture and identify cells of S. aureus from swab specimens. The success of
this combination could allow for the accurate diagnosis of S. aureus infection in 4-8
hours, as opposed to traditional culture based methods which take up to 24-48 hours.
Developing these methods for rapid capture and identification of S. aureus could lead to
improve patient outcomes by resulting in faster treatment administration.
In addition, my thesis seeks to answer the following questions: 1) can S. aureus be
identified from solid agar plates by laser-light scattering analysis, 2) can S. aureus be
specifically separated from samples using IMS and 3) in combination with IMS, can
laser-light scattering analysis increase the speed and accuracy of S. aureus identification?
Our goal is to determine if the combination of IMS and laser-light identification can
accurately identify S. aureus in swab samples while decreasing the total identification
time to 4-8 hours. We hypothesized that anti-Protein A conjugated magnetic DynaBeads
(also referred to as, anti-Protein A DynaBeads) would bind to surface Protein A on S.
aureus in a swab sample and facilitate their isolation upon exposure to a magnetic field
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within a 4-8 hour procedure. S. aureus cells isolated by IMS can then be accurately
identified using MIT technology in less than 5 minutes.
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CHAPTER TWO: SINGLE LASER-LIGHT SCATTERING

INTRODUCTION
Laser-light scattering technology developed by MIT measures laser-light
scattering intensity as individual microbes pass through a laser beam. The light scattering
pattern is influenced by the size, shape, external and internal optical characteristics, and
the motility of the microbe. In order to identify microbes via laser-light scattering, the
bacteria must first be grown on agar plates. Due to the possibility that different bacteria
growth media types may influence bacteria cell size and shape, we needed to determine if
the accuracy of bacterial identification was dependent on the growth media that the
bacteria was grown on. To test this, four common types of growth media were used to
evaluate if the media type influenced the laser-light scattering patterns and identification
accuracy of the MIT 1000. To perform this analysis, 10 Staphylococcus species and 6
negative control strains were tested a minimum of 10 times in the MIT 1000. Percent
identified as Staphylococcus species was calculated for each growth media type.
The identification technology developed by MIT was generated by measuring
thousands of laser-light scattering measurements of known bacterial strains in order to
develop an Identifier specific to that bacteria. Previous studies have shown that
laboratory and clinically isolated strains can differ in size and shape despite being the
same species 71. With this in mind, we needed to assess the accuracy of the device from
both laboratory and clinical strains. To further assess the accuracy of MIT 1000 bacterial
identification technology, a single blind study was conducted using clinical isolates
obtained from UP Health System-Marquette. In total, 90 clinical isolates were obtained
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from UP Health System-Marquette on blood plates. The identity of the bacteria isolates
was not revealed to our lab until all identification tests with the MIT 1000 were
completed. Each clinical isolate was identified using the MIT instrument and
identifications were conducted a minimum of 3 times for each strain. Percent identified
as Staphylococcus species was calculated and MIT identifications were compared to
hospital determined identifications.
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METHODS

Bacterial strains and culture conditions
S. aureus 6538 (ATCC) was used as the positive control in all experiments
conducted during this project. S. aureus 6538 has a history of use in quality control
testing, food testing, and other laboratory applications 79. This strain was initially isolated
from a human lesion. Other strains that were utilized in this study are displayed in Table
2. All bacterial strains were grown in tryptic soy broth (TSB, Hardy Diagnostics) at 37 ͦ C
for 18 hours in aerobic conditions with the exception of S. pyogenes which was grown in
reduced oxygen conditions (candle jars). Bacterial cultures were grown in liquid TSB
media shaken at 200 rpm and incubated at 37 ͦ C for 18 hours.
Table 2. Bacterial strains used in this study. Bacterial strains and strain source are listed.
Bacteria Strain
Source
Bacillus subtilis 11774
ATCC
Enterobacter aerogenes 35029
ATCC
Enterococcus faecalis 7080
ATCC
Escherichia coli 29543
ATCC
Listeria monocytogenes 19115
ATCC
Micrococcus luteus SK58
BEI Resources
Serratia marcescens 14756
ATCC
Staphylococcus aureus 25923
ATCC
Staphylococcus aureus 29213
ATCC
Staphylococcus aureus 6538
ATCC
Staphylococcus aureus F003B2N-C
BEI Resources
Staphylococcus aureus HI022
BEI Resources
Staphylococcus epidermidis 35983
ATCC
Staphylococcus epidermidis 49134
ATCC
Staphylococcus epidermidis 49461
ATCC
Staphylococcus epidermidis SK135
BEI Resources
Staphylococcus intermedius 29663
ATCC
Staphylococcus simulans (Clinical isolate)
UP Health System- Marquette
Streptococcus agalactiae MNZ933
BEI Resources
Streptococcus pyogenes MGAS 1882
BEI Resources
Streptococcus salivarius SK126
BEI Resources
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Rapid MIT identification from agar colonies
MIT identification procedure from agar plates
Colonies were removed from an agar plate using a sterile loop. The bacteria
collected on the loop were dislodged into a microcentrifuge tube that contained about 200
µl of filtered water (3 stage water filter by Watts (North Andover, MA), three stages of
filtration (1) sediment, (2) pre-carbon, and (3) VF, 0.6 µm membrane). The
microcentrifuge tubes were vigorously agitated by vortexing (20-30 seconds) to
dissociate the bacterial cells. The MIT sample vial were inoculated (15 ml round bottom
flask, VWR) with about 1 µl of the bacterial suspension. The top of the vial was covered
with parafilm (VWR). The MIT sample vial was then secured with parafilm by a rubber
band (VWR) and the vial was tipped to resuspend the bacteria. Sample preparation was
the same for all species of bacteria. The prepared sample was then placed into the MIT
system (MIT 1000). To run the MIT 1000, the User selects the “Identify” button on the
MIT Interface Program. The program runs the test and the result was displayed within 25 minutes.
Laser-light scattering analysis of bacteria grown on solid media
In order to determine if accuracy of bacteria identification was dependent on the
type of growth media used to culture the organisms, the accuracy of the laser-scattering
technology was challenged by growing known bacteria strains on 4 different solid media.
Various Staphylococcus species and negative controls were grown on different medium
in order to determine if the type of growth media effected the accuracy of identification.
Media utilized in this analysis were common laboratory media: blood agar (Hardy
Diagnostics), brain heart infusion agar (BHI, Hardy Diagnostics), lysogeny broth (LB,
Hardy Diagnostics), and tryptic soy broth (TSB, Hardy Diagnostics). Strains utilized in
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this analysis: S. aureus 25923, S. aureus HI022, S. aureus 29213, S. aureus 6538, S.
aureus F003B2NL, S. epidermidis 49461, S. epidermidis 49134, S. epidermidis 35983, S.
epidermidis SK135, S. intermedius 29663, S. pyogenes MGAS 1882, Streptococcus
agalactiae MNZ 933, Streptococcus salivarius SK126, and M. luteus SK58. Each strain
was tested in the MIT 1000 a minimum of 10 times for each media using MIT
identification procedure from agar plates protocol.
Rapid MIT identification from clinical specimens obtained by UP Health System
Marquette: A single blind study (Appendix A, approval to use clinical specimens from
UP Health System Marquette)
Clinically isolated strains of bacteria can differ significantly from laboratory
adapted strains. A single blind study was conducted using bacteria isolated from clinical
samples. This single blind study was conducted to evaluate the MIT 1000’s ability to
identify bacteria from real patient samples rather than laboratory strains. The identities of
the bacteria samples were known by UP Health System- Marquette and unknown to our
laboratory. In total, 90 clinical isolates were obtained from UP Health System on blood
agar plates. Colonies from these 90 clinical isolates were measured a minimum of 3 times
in the MIT instrument to determine the accuracy of identification of clinical strains of
bacteria. The set of clinical isolates sent to our laboratory included Staphylococcus
species as well as a subset of unknown negative controls. All samples were tested using
the MIT identification procedure from colonies on agar plates mentioned above. After all
identification measurements were made, our results were compared to the known
identifications made by the UP Health Systems Microbiology Laboratories. The succesful
identification of all clinically isolated Staphylococcus strains was proof of concept that
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light-scattering technology could identify laboratory strans as well as clinical isolates of
Staphylococcus species.
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RESULTS

Analysis of MIT identification of bacteria grown on different media
In order to determine if the accuracy of bacteria identification was dependent on
the type of growth media used to culture the organisms, organisms were grown on four
different commercially available agar plates and tested using the MIT 1000. Ten
Staphylococcus species were used as positive controls and 6 negative controls strains
were also utilized. Each strain was tested in the MIT 1000 a minimum of 10 times and the
percent identified as Staphylococcus species was calculated.
The average percent identified as Staphylococcus species using the MIT 1000 of
the 10 Staphylococcus strains on blood agar was 97.3% + 3.59 ; while the 6 negative
controls strains had an average of 3% + 2.45 miss-identified as Staphylococcus species.
The average percent identified as Staphylococcus species of the 10 Staphylococcus
strains on BHI agar was 97.0% + 4.22 ; while the 6 negative controls strains had an
average of 0.83% + 2.04 miss-identified as Staphylococcus species. The average percent
identified as Staphylococcus species of the 10 Staphylococcus strains on LB agar was
96.4% + 3.89; while the 6 negative controls strains had an average of 0.83% + 2.04 missidentified as Staphylococcus species. The average percent identified as Staphylococcus
species of the 10 Staphylococcus strains on TSB agar was 97.1% + 3.96 ; while the 6
negative controls strains had an average of 0% + 0.00 miss-identified as Staphylococcus
species. Overall, greater than 95.00% of the positive Staphylococcus species identified as
Staphylococcus species using the MIT 1000 and less than 5.00% of the nonStaphylococcus negative controls miss-identified as Staphylococcus species. This
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displays that bacterial identification by the MIT 1000 is not dependent upon growth
media.
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Figure 11. Percent identified as Staphylococcus species grown on blood agar. Positive
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average
of 97.3% + 3.59. The false positive rate of non-Staphylococcus species miss-identified as
Staphylococcus species using the MIT 1000 an average of 3% + 2.45.
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Figure 12. Percent identified as Staphylococcus species grown on BHI agar. Positive
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average
of 97.0% + 4.22. The false positive rate of non-Staphylococcus species miss-identified as
Staphylococcus species using the MIT 1000 an average of 0.83% + 2.04.
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Figure 13. Percent identified as Staphylococcus species grown on LB agar. Positive
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average
of 96.4% + 3.89. The false positive rate of non-Staphylococcus species miss-identified as
Staphylococcus species using the MIT 1000 an average of 0.83% + 2.04.
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Figure 14. Percent identified as Staphylococcus species grown on TSB agar. Positive
Staphylococcus species identified as Staphylococcus species using the MIT 1000 an average
of 97.1% + 3.96. The false positive rate of non -Staphylococcus species miss-identified as
Staphylococcus species using the MIT 1000 an average of 0.00% + 0.00.

Single blind study- MIT identification from clinical specimens
In total, our lab obtained 90 clinical isolates on blood plates from UP Health
System Marquette. Our lab obtained 30 isolates in a month’s duration. The isolates were
supplied on blood agar, and only a number as an identifier. The hospital-determined
identity of the bacteria isolates were not revealed to our laboratory until we finished all of
the identification tests with the MIT 1000. Each strain was identified using the MIT
instrument and identifications were conducted a minimum of 3 times for each strain. In
this single blind study 100% of the Staphylococcus species sent to us by the hospital were
correctly identified by the MIT instrument (Table 3). In addition, there were no falsepositive results. None of the non-Staphylococcus bacteria misidentified as
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Staphylococcus species, which provides evidence of the MIT instrument’s accuracy on
both laboratory and real patient samples.

Table 3. Results of a single blind study. A total of 90 de-identified bacterial
isolates were submitted to NMU for identification with the MIT 1000. Each strain
isolate was measured at least 3 times in the MIT 1000. Staphylococcus species are
highlighted in yellow. Other Gram positive cocci are in red. Gram negative cocci
are in blue.
De-identified hospital
MIT 1000 identified as
Hospital clinical isolates
isolates tested in the MIT
Staph. spp.
1000
Corynebacterium
1
0
diphtheriae
Corynebacterium spp.
1
0
Enterobacter cloacae
1
0
Enterococcus faecalis
13
0
Enterococcus faecium
1
0
Enterococcus spp.
2
0
Escherichia coli
14
0
Klebsiella pneumoniae
5
0
Methicillin Resistant S.
8
8
aureus
Neisseria spp.
1
0
Proteus mirabilis
4
0
Providencia rettgeri
1
0
Pseudomonas aeruginosa
2
0
Staphylococcus aureus
16
16
Staphylococcus
4
4
epidermidis
Staphylococcus simulans
1
1
Staphylococcus spp.
1
1
(Coagulase negative)
Streptococcus group A
4
0
Streptococcus group B
4
0
Streptococcus group C
1
0
Streptococcus group D
1
0
(not Enterococcus spp.)
Streptococcus
1
0
pneumoniae
Viridans streptococci
3
0
90
30
Totals:
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DISCUSSION

Staphylococcus aureus is the most commonly isolated human associated bacterial
pathogen. It plays an important role in skin and soft-tissue infections, pneumonia,
endocarditis, osteomyelitis, foreign-body infections, and sepsis 21,69. S. aureus is typically
identified by coagulase tests or latex agglutination tests; however, identification can also
be achieved by detection of Protein A production and heat-stable nuclease 8. Molecular
based tests, such as PCR are conducted by way of S. aureus-specific genetic targets. The
time until diagnosis of S. aureus infections can range from 24-48 hours depending upon
the identification method 10. With this in mind, it has been shown that faster pathogen
identification has been linked to improved patient outcome 49. The impact of faster
identification on patient outcome has led us to test alternative methods of S. aureus
identification. As an alternative to traditional bacteria identification, single cell laser-light
scattering technology (MIT 1000 instrument) was utilized as a form of rapid
identification of S. aureus. In as little as 5 minutes, this technology identifies a pure
bacteria sample by comparing laser-light scattering patterns to known scattering patterns
(Identifier) in its database. MIT has received AOAC certification for their Listeria
species Identifier and will soon receive certification for their Staphylococcus species
Identifier.
In this section, we addressed the following questions: does the growth media that
the bacteria is grown with effect the accuracy of identification and can S. aureus be
identified by single cell laser-light scattering technology and, if so, how accurately? We
also asked the question, can laser-light scattering technology identify laboratory strains
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and clinical isolates with the same rate of accuracy? To evaluate the effect of growth
media on MIT 1000 identification and the accuracy of identification of laboratory strains,
10 Staphylococcus species and 6 non-Staphylococcus negative control species were tested
in 4 different types of common media types (Figures 11-14). Based on the media
analysis, we determined that the type of media does not significantly affect the accuracy
of MIT 1000 identification on either positive or negative control strains. TSB agar
performed the best when considering false positive results, displaying 0.00% + 0.00 of
the negative controls miss-identifying as Staphylococcus species. Considering these
results, we chose to perform further experiments with TSB media. TSB media also has
common overlapping ingredients including: sodium chloride, dextrose, and soybean meal
with LB, BHI, and blood agar which further supports our decision to utilize TSB as our
main media type.
Previous studies have highlighted significant differences in the genomes of
laboratory strains and clinical isolates, which may lead to phenotypic changes to the
microbes physical structure 71. Due to the importance of cell size and shape in laser-light
scattering identification, and the knowledge that laboratory and clinical isolates differ,
both laboratory and clinical isolates were utilized in the testing of laser-light scattering
identification accuracy. A single blind study was conducted in order to address the
question, can laser-light scattering technology identify laboratory strains and clinical
isolates with the same rate of accuracy. We performed a single blind study in
collaboration with UP Health System- Marquette, which included a total of 90 deidentified bacterial isolates. Each of these clinical isolates were identified a minimum of
3 times with the MIT 1000. The provided clinical isolates not only included various
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strains of Staphylococcus species (MRSA, S. aureus, S. epidermidis, and S. simulans),
but also included Gram positive and negative cocci and rods. Of the 30 Staphylococcus
clinical strains, all 30 accurately identified as Staphylococcus species using laser-light
scattering technology. In addition, the remaining non-Staphylococcus species did not
generate any inaccurate Staphylococcus species identifications.
When comparing the results of laboratory versus clinical strains, it was
hypothesized that laboratory strains would identify with greater accuracy using laser-light
scattering than clinical isolates because laboratory strains were utilized to develop MIT
Identifiers. Our results displayed 100% identification accuracy when identifying clinical
isolates; while laboratory strains displayed identification accuracy greater than 95.0%.
Clinical isolates were tested a minimum of 3 times with the MIT 1000; while laboratory
strains were identified a minimum of 10 times. After performing these replication, we did
not observe conflicting identifications in the samples tested. Overall, our concern that
laser-light scattering identification could not be translated to clinical isolates was
addressed. We can conclude that there is no significant difference in the identification
accuracy between clinical isolates and laboratory strains. Additionally, none of the
growth media tested displayed significant differences in bacterial identification accuracy.
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CHAPTER THREE: IMMUNOMAGNETIC SEPARATION VIA ANTI-STAPH
DYNABEADS

INTRODUCTION
Prior to the use of anti-Protein A DynaBeads, anti-Staph DynaBeads were utilized
for S. aureus capture via IMS methods. Anti-Staph antibodies are antibodies raised
against whole S. aureus cells as opposed to anti-Protein A antibodies which are raised
against a surface protein specific to S. aureus. Specificity of anti-Staph DynaBeads for S.
aureus was evaluated by determining the capture ability of the antibodies. We
hypothesized that the anti-Staph antibodies conjugated to DynaBeads would specifically
capture a significant concentration of S. aureus cells in both pure and mixed specimen
samples.
In order to determine specificity for S. aureus, anti-Staph DynaBeads were added
to pure samples of S. aureus and M. luteus. The anti-Staph DynaBeads were then mixed
for 1 hour for binding and washed to remove non-bound cells from the sample. The
washed anti-Staph DynaBeads were then spot plated on agar plates and incubated at 37 ͦ C
for 18 hours. To further assess anti-Staph DynaBead specificity for S. aureus, anti-Staph
DynaBeads were added to separate samples containing S. aureus and other negative
controls, B. subtilis, M. luteus, and S. marcescens, mixed for 1 hour for binding and
washed to remove non-bound cells from the sample. The washed anti-Staph DynaBeads
were then spread plated on agar plates to determine the capture efficiencies for the antiStaph DynaBeads when combined with positive and negative control strains. S. aureus
mixed samples were also utilized to generate a more complex sample and replicate more
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realistic sample collections. In order to determine the specificity of anti-Staph DynaBeads
for S. aureus in mixed samples, S. aureus was mixed with each of the negative control
strains: M. luteus, S. marcescens, and B. subtilis. Anti-Staph DynaBeads were added to
each sample, mixed for 1 hour for binding and washed to remove non-bound cells from
the sample. The anti-Staph DynaBeads were then quadrant streaked, incubated at 37 ͦ C
for 18 hours and captured colonies were observed. The results of these experiments
allowed us to determine the binding specificity and capture efficiency anti-Staph
DynaBeads had for S. aureus and other negative control strains.
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METHODS

Preparation of anti-Staphylococcus DynaBeads
Anti-Staph antibodies (Life Technologies) are antibodies raised against whole S.
aureus cells as opposed to anti-Protein A antibodies which are raised against surface
proteins specific to S. aureus. Anti-Staph DynaBeads were prepared as follows: 100 µL
of magnetic beads (M-280 Streptavidin DynaBeads, Life Technologies) were transferred
into a microcentrifuge tube and magnetically separated for 3 minutes in order to remove
the storage buffer. The DynaBeads were resuspended in 450 µL of phosphate buffer
saline (PBS, NaCl 137mM, KCl 2.7 mM, Na2HPO4 10mM, KH2PO4 1.8 mM) and mixed
by a rotator (VWR, 10136-084) for 1 minute at room temperature. The DynaBeads were
magnetically separated for 3 minutes, PBS was removed and the DynaBeads were
resuspended in 450 µL of PBS. This process was repeated for a total of 3 washes. The
prepared DynaBeads were stored in 100 µL of PBS and held at 4 ͦ C.
Prepared DynaBeads were combined with 20 µL of biotin conjugated chicken
anti-Staph antibodies (1 mg/ml, Life Technologies) and rotated for 1 hour. The
DynaBeads and antibody mixture (now referred to as, anti-Staph DynaBeads) was then
magnetically separated for 3 minutes. The PBS was removed and the anti-Staph
DynaBeads were resuspended in 450 µL of PBS and rotated for 1 minute at room
temperature. The anti-Staph DynaBeads were then magnetically separated for 3 minutes.
This washing process was repeated for a total of 4 washes. The washed anti-Staph
DynaBeads were stored in 100 µL of PBS and held at 4 ͦ C.
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Development of IMS methods via anti-Staph DynaBeads and specificity testing
To determine the capture efficiencies of the anti-Staph DynaBeads to S. aureus in
pure culture, bacterial specimens were 10-fold serial diluted from an overnight culture
(Undiluted overnight culture to 10-7) in 450 µL of filtered TSB, 20 µL of the anti-Staph
DynaBeads were added to the specimens and rotated for 1 hour at 22 ͦ C. The samples
were then magnetically separated for 1 minute, the TSB was removed and anti-Staph
DynaBeads were resuspended in 450 µL of wash buffer, PBS plus 0.01% bovine serum
albumin (BSA, VWR). The samples were then rotated for 1 minute at room temperature
and then magnetically separated for 1 minute. This process was repeated for a total of 4
washes. The anti-Staph DynaBeads were then transferred into a sterile microcentrifuge
tubes with 100 µL of PBS. The transfer liquid (PBS) was then removed and the
DynaBeads were resuspended in 100 µl of PSB. The dilutions were then spot plated (5
µl) to determine the binding specificity of the anti-Staph DynaBeads for S. aureus. M.
luteus was used as a negative control. To further determine the specificity of anti-Staph
DynaBeads, serial dilutions were created for S. aureus, as previously described, and
mixed with 20 µl of anti-Staph DynaBeads for one hour. The solution from the 10-4
dilution was spread plated on LB media and incubated at 37◦C for 18 hours. M. luteus, S.
marcescens, and B. subtilis were used as negative controls. Plates were observed after 18
hours and growth was recorded.
Anti-Staph DynaBead specificity for S. aureus capture when challenged with a
mixture of other bacteria was also conducted. Serial dilutions were created as previously
mentioned with equal amounts of S. aureus and M. luteus, S. aureus and S. marcescens,
and S. aureus and B. subtilis. S. aureus in combination with B. subtilis was plated on LB
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agar, S. aureus in combination with S. marcescens was plated on LB agar, and S. aureus
in combination with M. luteus was plated on MSA agar to differentiate between S. aureus
and M. luteus. This experiment allowed us to determine anti-Staph DynaBead specify for
S. aureus alone, when challenged with other negative control bacteria.
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RESULTS

Anti-Staph DynaBead specificity testing
To determine the capture efficiencies of the anti-Staph DynaBeads to S. aureus in
pure culture, 20 µl of conjugated anti-Staph DynaBeads were mixed with 10-fold serial
dilutions of overnight cultures (Undiluted to 10-7) of S. aureus for one hour. The dilutions
were then spot plated to determine the binding specificity of the anti-Staph DynaBeads
for S. aureus. M. luteus was used as a negative control. Figure 15 displays binding of S.
aureus to anti-Staph DynaBeads and only minimal binding for M. luteus the negative
control in the undiluted concentration. To further determine the specificity of anti-Staph
DynaBeads, serial dilutions were created for S. aureus, as previously described, and
mixed with conjugated anti-Staph

Figure 15. Binding specificity for anti-Staph DynaBeads for S. aureus in pure culture
spot plates. 5 µl of bound anti-Staph DynaBeads were spot plated on LB media for
each dilution to display the bacteria that has bound to the anti-Staph DynaBeads. M.
luteus was used as a negative control.
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Figure 16. Binding specificity for anti-Staph DynaBeads for S. aureus in
pure culture. 100 µl of bound anti-Staph DynaBeads were spread plated
on LB media to display anti-Staph DynaBead specificity for S. aureus.
M. luteus, S. marcescens, and B. subtilis were used as negative controls.
Nonspecific binding was observed.

DynaBeads for one hour. The solution from the 10-4 dilution was spread plated on LB
media and incubated at 37◦C for 18 hours. M. luteus, S. marcescens, and B. subtilis were
used as negative controls. Figure 16 displays anti-Staph DynaBeads ability to bind S.
aureus as well as other negative controls. A final experiment was used to determine antiStaph DynaBead specificity for S. aureus when challenged with other bacteria (Figure
17). Serial dilutions were created as previously mentioned with equal amounts of S.
aureus and M. luteus, S. aureus and S. marcescens, and S. aureus and B. subtilis. The
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results displayed specificity for S. aureus when challenged with M. luteus (Figure 17C);
however when challenged with B. subtilis and S. marcescens the anti-Staph DynaBeads
did not display full specificity for S. aureus alone.
The preliminary experiments using anti-Staphylococcus antibodies and
DynaBeads displayed the ability to capture both S. aureus and multiple negative controls
but not S. aureus specifically. These findings suggest that a more specific antibody was
necessary to isolate S. aureus alone. Therefore, we proposed to use antibodies against
Protein A, a surface protein specific to S. aureus but not S. epidermidis or other negative
controls, to isolate S. aureus from mixed samples 18.

Figure 17. Binding specificity of anti-Staph DynaBeads for S. aureus when challenged
with equal amounts of negative control bacteria. A. S. aureus in combination with B.
subtilis plated on LB agar, showing presence of both bacteria, B. S. aureus in
combination with S. marcescens plated on LB agar, showing presence of both bacteria,
and C. S. aureus in combination with M. luteus plated on Mannitol Salt agar to
differentiate between S. aureus and M. luteus, showing specificity for S. aureus alone.
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DISCUSSION

Identification methods, such as single laser-light scattering have the ability to
rapidly identify pathogens and lead to the quicker administration of treatments. However,
rapid identification needs to be paired with a method of rapid capture or isolation of that
bacteria prior to identification. In order to bypass the lengthy step of growing bacteria on
agar plates, we proposed to utilize IMS as our mode of S. aureus isolation prior to rapid
laser-light identification. Previous studies have utilized IMS in order to isolate L.
monocytogenes from pure culture and from contaminated whole milk and ground beef
samples.
Utilizing anti-Staph antibodies which are antibodies raised against whole S.
aureus cells, our data initially displayed binding of S. aureus to anti-Staph DynaBeads
and only minimal binding for M. luteus the negative control in the undiluted
concentration (Figure 15). The deduced that the presence of minimal growth of M. luteus
on this spot plate could have been due to inefficient washing methods or due to direct
binding of M. luteus to anti-Staph DynaBeads.
To further determine the specificity of anti-Staph DynaBeads, 10-fold serial
dilutions from overnight cultures were created for S. aureus, and mixed with anti-Staph
DynaBeads for one hour. The solution from the 10-4 dilution was spread plated on LB
media. M. luteus, S. marcescens, and B. subtilis were used as negative controls. Figure 16
displayed anti-Staph DynaBeads ability to capture S. aureus with high efficiency. In
addition to a high capture rate for S. aureus, S. marcescens and B. subtilis were captured
at a high rate when combined with anti-Staph DynaBeads. We speculate that the high
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capture rate of S. marcescens and B. subtilis could be attributed to non-specific binding of
these microbes to the antibodies, DynaBeads, or surfaces of the microcentrifuge tubes. M.
luteus, much like the results displayed in Figure 15, was captured at a low rate by antiStaph DynaBeads.
A final experiment was used to determine anti-Staph DynaBead specificity for S.
aureus when challenged with other bacteria (Figure 17). The results displayed specificity
for S. aureus when challenged with M. luteus (Figure 17C); however when challenged
with B. subtilis and S. marcescens the anti-Staph DynaBeads did not display full
specificity for S. aureus alone (Figure 17A and 17B). These results suggest that the nonspecific binding was occurring during our IMS procedure. The non-specific binding
could have been attributed to inadequate washing during the IMS procedure or due to the
anti-Staph antibody. If non-specific binding was due to the antibody itself, we speculate
that the antibody was developed to bind to a cell surface protein that may be commonly
found on the surfaces of many microbes, resulting in the binding of not only S. aureus but
other negative control strains.
The experiments using anti-Staphylococcus antibodies and DynaBeads displayed
the ability to capture both S. aureus and multiple negative controls but not S. aureus
specifically. The anti-Staph DynaBeads are raised against whole S. aureus cells, rather
than to a specific antigen found on the surface of S. aureus. Due to this feature of antiStaphylococcus antibodies, the antibodies have the potential to recognize and bind to the
surface of many bacteria species. These findings suggest that a more specific antibody is
necessary to isolate S. aureus alone. Therefore, we propose to use antibodies against
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Protein A, a surface protein specific to S. aureus but not S. epidermidis or other negative
controls, to isolate S. aureus from samples containing a mixture of bacteria 18.
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CHAPTER FOUR: IMMUNOMAGNETIC SEPARATION OF S. AUREUS VIA
ANTI-PROTEIN A DYANBEADS

INTRODUCTION
Due to anti-Staph DynaBeads lack of specificity for S. aureus, we proposed to use
antibodies against Protein A, which is specific for a surface protein unique to S. aureus in
order to isolate S. aureus 18. Prior to specificity testing, we first needed to determine the
optimal conditions for anti-Protein A DynaBead preparation and capture methods. Wash
conditions were first evaluated to determine their effect on non-specific binding and the
removal of unbound bacteria that could potentially be stuck to the walls or cap of
microcentrifuge tubes. The following wash buffers were evaluated for washing
efficiency: PBS, PBS + 0.1% BSA, and PBS + 0.01% Tween 20.
After the establishment of optimal anti-Protein A DynaBead preparation and
capture methods, we needed to determine anti-Protein A DynaBeads ability to capture S.
aureus. To evaluate anti-Protein A DynaBead specificity for S. aureus, anti-Protein A
DynaBeads were added to pure culture samples of S. aureus, mixed for 1 hour, washed
with PBS + 0.01% Tween. The anti-Protein A DynaBeads were spread plated on agar
plates and then incubated at 37 ͦ C for 18 hours. Capture efficiencies were then calculated
and statistical significance was determined via one-way ANOVA Bonferroni multiple
comparison test. This process was repeated with a diverse group of negative control
strains. We hypothesized that anti-Protein A DynaBeads would have greater specificity
for S. aureus than did anti-Staph DynaBeads. We further hypothesized that anti-Protein A
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DynaBeads would specifically capture a significant concentration of S. aureus cells in
both pure and mixed specimen samples.
After determining anti-Protein A DynaBeads ability to capture S. aureus in pure
cultures, we then sought to determine if our IMS methods could capture S. aureus from a
more complex biological sample. To evaluate this, we performed our methods in whole
milk which contains many competing proteins, enzymes, and other microbial species. We
hypothesized that anti-Protein A DynaBeads would have specificity for S. aureus in
whole milk; however, there would be a reduction in capture efficiency due to the increase
in competing cells, fats, proteins, and particulates within the whole milk. In order to
determine this, anti-Protein A DynaBeads were added to whole milk containing S. aureus
and capture efficiencies and statistical significance were calculated. This process was
repeated with negative control strains that could be connected to milk contamination (B.
subtilis and L. monocytogenes).
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METHODS

Preparation of anti-Protein A DynaBeads
Anti-Protein A DynaBeads were prepared as follows: 100 µL of magnetic beads
(M-280 Streptavidin DynaBeads, Life Technologies) were transferred into a
microcentrifuge tube and magnetically separated (Dynamag2, Life Technologies) for 3
minutes in order to remove the storage buffer. The DynaBeads were resuspended in 450
µL of PBS and mixed by a rotator for 1 minute at room temperature. The DynaBeads
were magnetically separated for 3 minutes, PBS was removed and the DynaBeads were
resuspended in 450 µL of PBS. This process was repeated for a total of 3 washes. The
prepared DynaBeads were stored in 100 µL of PBS and held at 4 ͦ C.
Prepared DynaBeads were combined with 20 µL of biotin conjugated chicken
anti-Protein A antibodies (1 mg/ml, ICL lab) and rotated for 1 hour. The DynaBead and
antibody mixture (now referred to as, anti-Protein A DynaBeads) were then magnetically
separated for 3 minutes. The PBS was removed and the anti-Protein A DynaBeads were
resuspended in 450 µL of PBS and rotated for 1 minute at room temperature. The antiTable 4. Summary table of optimal conditions for enrichment step. This table
includes the variations in variables for each experiment performed above.
Optimal conditions are highlighted in yellow
Binding
Conditio
Growth
Moveme
Bead
Growth Media
Temperatur
n
Media
nt
Removal
Removal
e
1
TSB
22 ͦ C
No
No
No
2
TSB
37 ͦ C
No
No
No
ͦ
3
TSB
37 C
215 rpm No
No
ͦ
4
TSB
37 C
250 rpm No
No
5
TSB
37 ͦ C
250 rpm Yes
No
ͦ
6
Terrific Broth 37 C
250 rpm Yes
No
7
TSB
37 ͦ C
250 rpm Yes
Yes
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Protein A DynaBeads were then magnetically separated for 3 minutes. This washing
process was repeated for a total of 4 washes. The washed anti-Protein A DynaBeads were
stored in 100 µL of PBS and held at 4 ͦ C. Optimal conditions are shown highlighted in
yellow in Table 4.
ImmunoMagnetic Separation of S. aureus via anti-Protein A DynaBeads
Development of IMS methods via anti-Protein A DynaBeads
Bacterial strains were grown in TSB at 37 ͦ C for 18-24 hours. Ten-fold serial
dilutions from overnight cultures of S. aureus were made in TSB media for experiments
evaluating ImmunoMagnetic Separation and laser-light scatting identification.
Fifty microliters of overnight bacterial cultures were 10-fold serial diluted in 450
µL of filtered TSB (10-2-10-6), 20 µL of the anti-Protein A DynaBeads were added to the
specimens and rotated for 1 hour at either 22 ͦ C or 37 ͦ C. The samples were then
magnetically separated for 1-3 minutes, the TSB was removed and anti-Protein A
DynaBeads were resuspended in 450 µL of wash buffer, PBS alone, PBS plus 0.1%
bovine serum albumin (BSA, VWR), or PBS plus 0.01% Tween 20 (VWR). The samples
were then rotated for 1 minute at room temperature and then magnetically separated for
1-3 minutes. This process was repeated for a total of 4 washes. The anti-Protein A
DynaBeads were then transferred into a sterile microcentrifuge tubes with 100 µL of
PBS. The transfer liquid (PBS) was then removed and the DynaBeads were resuspended
in 100 µl of PBS. The experimental conditions (magnetic separation time, wash buffer,
tube type, and binding temperatures) were adjusted to determine the most efficient means
for ImmunoMagnetic separation of targeted bacterial specimens.
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To determine the efficiency of the anti-Protein A DynaBead protocol, the washing
buffers were first evaluated. To determine if the wash buffer altered non-specific binding
of bacteria to the walls or cap of microcentrifuge tubes, the use of PBS and PBS + 0.1%
BSA were evaluated for washing efficiency. In order to evaluate the efficiency of each
buffer, 10-fold serial dilutions (10-3 to 10-7) of overnight S. aureus cultures were created
in TSB. To each dilution, 20 µl of anti-Protein A DynaBeads were added, rotated for 1
hour, magnetically separated for 3 minutes and washed with 450 µl of either PBS or PBS
+ 0.1% BSA. After adding 450 µl of appropriate wash buffer, the tubes were rotated for 1
minute at 22 ͦ C, magnetically separated for 3 minutes and washed with 450 µl of the
appropriate wash buffer. This process was repeated for a total number of 4 washed. The
washed anti-Protein A DynaBeads were then resuspended in 100 µl of PBS and 5 µl of
the solution was spot plated on TBS agar plates and incubated at 37 ͦ C for 18 hours.
Another 10-fold serial dilution set (10-3 to 10-7) was generated and 20 µl of DynaBeads
alone were added and the same protocol was repeated. This dilution set was created to
evaluate wash efficiency by media type.
PBS and PBS + 0.01% Tween 20 were then evaluated for their ability to reduce
non-specific binding. To evaluate, S. aureus was 10-fold serial diluted (10-3 to 10-6) from
overnight cultures in 450 µl of TSB. To each dilution, 20 µl of anti-Protein A DynaBeads
were added and the same IMS protocol as above was repeated. The wash buffer under
evaluation were either PBS or PBS + 0.01% Tween 20. Another serial dilution set (10-3
to 10-6) was generated and 20 µl of DynaBeads alone were added. After the washes, 100
µl of each dilution was spread plated on TSB agar plates and incubated at 37 ͦ C for 18
hours and colonies were counted in order to calculate and compare capture efficiencies.
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Established IMS protocol for S. aureus capture
Bacterial specimens were 10-fold serial diluted of overnight cultures (10-2 to 10-6)
in 450 µL of TSB, 20 µL of the anti-Protein A DynaBeads were added to the specimens
and rotated for 1 hour at 37 ͦ C. The samples were then magnetically separated for 3
minutes, the TSB was removed and anti-Protein A DynaBeads were resuspended in 450
µL of PBS plus 0.01% Tween 20. The samples were then rotated for 1 minute at room
temperature and then magnetically separated for 3 minutes. This process was repeated for
a total of 4 washes. The anti-Protein A DynaBeads were then transferred into sterile
microcentrifuge tubes with 50 µL of PBS. The transfer liquid (PBS) was then removed
and the DynaBeads were resuspended in 100 µl of PBS.
Specificity testing in pure culture
To determine anti-Protein A DynaBeads ability to capture S. aureus, 50 µl of S.
aureus were mixed in 450 µl of buffer and 10-fold serial diluted from overnight cultures
(10-1 to 10-8). Two sets of the same serial dilutions were prepared, 20 µl of anti-Protein A
DynaBeads were added to one set of dilutions and mixed for 1 hour. The tube set
containing the anti-Protein A DynaBeads were then magnetically separated and washed
with 450 µl of PBS plus 0.01% Tween 20 to remove any unbound cells. After 4 washes
the bound anti-Protein A DynaBeads were resuspended in 100 µl of PBS. Then 100 µl of
DynaBeads were then spread plated on TSB plates and incubated at 37oC for 18 hours.
Anti-Protein A DynaBeads were not added to the other set of dilutions. These dilutions
were utilized to determine the initial input of bacteria in each sample (input). To
determine the input for each dilution, each tube was vortexed for 10 seconds and 100 µl
was spread plated on TSB agar plates and incubated at 37oC for 18 hours. After
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incubation, colonies on each plate were counted and capture efficiencies were calculated.
Capture efficiencies (CE) are defined as the percentage fraction of total bacteria captured
on the surface of the anti-Protein A DynaBeads 90. Capture efficiencies are calculated
using the number of unbound cells in the starting dilution (input). The equation for
Capture efficiency is calculated using the following equation: Capture efficiency (%) =
(1-B/A) x 100% 90. A is the total number of cells present in the sample (CFU/ml) and B
is the number of cells unbound to the anti-Protein A DynaBeads (CFU/ml, input).
In a similar control experiment, S. epidermidis, S. intermedius, S. simulans, S.
pyogenes, M. luteus, L. monocytogenes, E. faecalis, E. coli, and B. subtilis were used as
negative controls to determine the anti-Protein A DynaBeads specificity for each.
Capture efficiencies were determined using the same protocol mentioned above. These
methods allowed us to determine the IMS binding limit (the fewest number of bacteria
able to bind in a sample).
Specificity testing in mixed culture
To determine the specificity anti-Protein A DynaBeads have for S. aureus when
challenged by other bacteria, S. aureus was mixed with an equal concentration of S.
epidermidis which is a normal flora bacteria found on the skin and should not bind to
anti-Protein A DynaBeads 15. To evaluate the specificity, serial dilutions were spread
plated using previously established methods and incubated for at 37o C for 18 hours.
Capture efficiencies were calculated and analyzed. These experiments were performed to
establish the capture limit and specificity for our IMS protocol. (Results not shown)
S. aureus IMS isolation from whole milk by anti-Protein A DynaBeads
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To determine anti-Protein A DynaBeads ability to capture S. aureus from whole
milk, S. aureus was 10-fold serial diluted from overnight cultures (10-2 to 10-6) in 450 µl
of pasteurized whole milk. Two sets of the same serial dilutions (10-2 to 10-6) were
prepared, 20 µl of anti-Protein A DynaBeads were added to one set of dilutions and
mixed for 1 hour. The tube set containing the anti-Protein A DynaBeads were then
magnetically separated for 3 minutes and washed with 450 µl of PBS plus 0.01% Tween
20 to remove any unbound cells. After 4 washes the bound anti-Protein A DynaBeads
were resuspended in 100 µl of PBS. The 100 µl of DynaBeads are then spread plated on
TSB plates and incubated at 37oC for 18 hours. Anti-Protein A DynaBeads were not
added to the other set of dilutions. These dilutions were utilized to determine the initial
input of bacteria in each sample (input). To determine the input for each dilution, each
tube was vortexed for 10 seconds and 100 µl was spread plated on TSB agar plates and
incubated at 37oC for 18 hours. After incubation, colonies on each plate were counted and
capture efficiencies were calculated.
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RESULTS

Analysis of anti-Protein A DynaBead S. aureus capture specificity
Development of anti-Protein A DynaBead protocol for S. aureus IMS capture
To determine the efficiency of the anti-Protein A DynaBead protocol, the washing
buffers were first evaluated. To determine if the wash buffer altered non-specific binding
of bacteria to the walls or cap of microcentrifuge tubes, or the DynaBeads themselves, the
use of PBS and PBS + 0.1% BSA were evaluated for washing efficiency. In order to
evaluate the efficiency of each media, 10-fold serial dilutions of overnight cultures (10-3
to 10-7) were generated with S. aureus. To each dilution, 20 µl of anti-Protein A
DynaBeads were added, rotated for 1 hour, and washed four times with 450 µl of either
PBS or PBS + 0.1% BSA. Another serial dilution set (10-3 to 10-7) was generated and 20

Figure 18. Binding capacity of anti-Protein A DynaBeads for S. aureus, PBS versus PBS +
0.1% BSA. After the addition of anti-Protein A DynaBeads and IMS protocol, samples were
resuspended in 100 µl of PBS and 5 µl of the solution was spot plated on TSB agar.
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µl of DynaBeads alone were
added. This dilution set was
created to evaluate wash
efficiency by media type. Figure
18 displays similar results in
both capture and washing
efficiency between PBS and PBS
+ 0.01% BSA. To prevent further
non-specific binding via wash
buffer, PBS and PBS + 0.01%
Tween 20 were then evaluated
for their ability to reduce nonspecific binding. To evaluate, S.
aureus was 10-fold serial diluted
from overnight cultures (10-3 to

Figure 19. Non-specific binding evaluated with different
wash buffer. PBS and PBS + 0.01% Tween 20 were
evaluated for their ability to reduce non-specific binding
during IMS protocol. (A) S. aureus input in 10-5 dilution
after 4 washes with PBS alone. (B) 10-5 S. aureus
dilution after 4 washes with PBS alone. (C) S. aureus
input in 10-5 dilution after 4 washes with PBS + 0.01%
Tween 20. (D) 10-5 S. aureus dilution after 4 washes
with PBS + 0.01% Tween 20.

10-6). To each dilution, 20 µl of anti-Protein A DynaBeads were added, rotated for 1 hour
at 22 ͦ C, and washed four times with 450 µl of either PBS or PBS + 0.01% Tween 20.
Another serial dilution set (10-3 to 10-6) was generated and 20 µl of DynaBeads alone
were added. After the washes with the appropriate media, 100 µl of each dilution was
spread plated and colonies were counted in order to calculate and compare capture
efficiencies. Figure 19 displays the colonies input into a sample compared to the nonspecific binding for the same dilution. When washed with PBS alone, the DynaBeads
alone (non-specific binding) displayed an average capture efficiency of 0.83% + 0.41.
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When washed with PBS + 0.01%
Tween 20, the DynaBeads alone
displayed an average capture
efficiency of 0.17% + 0.13.
Although, the media type did not did
not display a significant difference in
the option between PBS and PBS +
0.01% Tween 20, PBS + Tween did
perform better when reducing nonspecific binding. This led us to use
PBS + Tween as our main wash
buffer after the addition of anti-

Figure 20. Gram stain of anti-Protein A
DynaBeads bound to S. aureus. Gram stain
was observed under 1000x magnification. S.
aureus are the purple cells (average diameter
is 0.6 µm) and the anti-Protein A DynaBeads
are shown as yellow spheres (diameter 2.8
µm).

Protein A DynaBeads to a sample. After using the established protocol, a gram stain of S.
aureus bound to anti-Protein A DynaBeads was conducted and imaged (Figure 20).
Analysis of capture efficiency and specificity of anti-Protein A DynaBeads for S.
aureus in pure culture
In order to determine anti-Protein A DynaBeads specificity for S. aureus, pure
cultures of S. aureus and 8 negative controls were utilized to determine capture
efficiencies for each strain when using anti-Protein A DynaBeads. To perform this
analysis, overnight cultures of the bacteria strains were 10-fold serial diluted (10-3 to 10-6)
in duplicate. One set of dilutions were utilized as the initial input of bacteria to the
sample and the second set was utilized in order to calculate the number of cells captured
by anti-Protein A DynaBeads (Figure 22 and 23). Capture efficiency was calculated as
follows: Capture efficiency (%) = (1-B/A) x 100% 90. A is the total number of cells
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present in the sample (CFU/ml) and B is the number of cells unbound to the anti-Protein
A DynaBeads (CFU/ml, input) (Table 5).
Capture efficiencies (%) were determined from pure culture samples. The average
capture efficiencies were as follows: S. aureus 78.21 + 2.01, B. subtilis 0.00 + 0.00, E.
faecalis 0.55 + 0.21, E. coli 0.00 + 0.00, M. luteus 0.00 + 0.01, S. epidermidis 0.26 +
0.34, S. intermedius 0.84 + 0.95, S. simulans 0.07 + 0.09, S. pyogenes 0.37 + 0.69.
Statistical analysis using one-way ANOVA with a Bonferroni multiple comparison test
displayed all negative controls to have P-values less than 0.001 when compared to S.
aureus 6538 (Figure 24).
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Figure 21. Anti-Protein A IMS capture for strains containing Protein A-like proteins. After 1
hour of anti-Protein A DynaBead exposure and a final wash (to remove unbound
bacteria), the anti-Protein A DynaBeads were resuspended in 100 µl of PBS and spread
plated on LB agar (10-6 dilution is pictured). (A) S. aureus input (the initial amount of
bacteria added to the sample without anti-Protein A DynaBead exposure) (B) S. aureus
bacteria captured (C) S. aureus combined with DynaBeads alone (D) S. intermedius input
(the initial amount of bacteria added to the sample without anti-Protein A DynaBead
exposure) (E) S. intermedius bacteria captured (F) S. intermedius combined with
DynaBeads alone.
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Figure 22. Specificity of conjugated anti-Protein A DynaBeads for negative controls
alone. After 1 hour of anti-Protein A DynaBead exposure and a final wash (to remove
unbound bacteria), the anti-Protein A DynaBeads were resuspended in 100 µl of PBS and
spread plated on LB agar (10-6 dilution is pictured). (A) S. epidermidis input (the initial
amount of bacteria added to the sample without anti-Protein A DynaBead exposure) (B)
S. epidermidis bacteria captured (C) S. epidermidis combined with DynaBeads alone (D)
S. pyogenes input (E) S. pyogenes bacteria capture (F) S. pyogenes combined with
DynaBeads alone (G) M. luteus input (H) M. luteus bacteria capture (I) M. luteus
combined with DynaBeads alone.
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Figure 23. Specificity of conjugated anti-Protein A DynaBeads for negative controls alone.
After 1 hour of anti-Protein A DynaBead exposure and a final wash (to remove unbound
bacteria), the anti-Protein A DynaBeads were resuspended in 100 µl of PBS and spread
plated on LB agar (10-6 dilution is pictured). (A) E. faecalis input (the initial amount of
bacteria added to the sample without anti-Protein A DynaBead exposure) (B) E. faecalis
bacteria captured (C) E. faecalis combined with DynaBeads alone (D) E. coli input (E) E. coli
bacteria capture (F) E. coli combined with DynaBeads alone. (G) B. subtilis input (H) B.
subtilis bacteria capture. (I) B. subtilis combined with DynaBeads alone.
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Table 5. Capture Efficiencies for anti-Protein A DynaBeads from pure culture.
Organism
Dilution
Capture Efficiency (%)
10-3
82.08 + 14.36
-4
10
82.08 + 14.36
S. aureus
-5
10
78.59 + 15.75
10-6
70.10 + 23.99
-3
10
0.84 + 0.20
10-4
0.84 + 0.20
S. epidermidis
-5
10
0.84 + 0.20
-6
10
0.25+ 0.50
10-3
0.37 + 0.31
-4
10
1.33 + 1.18
S. pyogenes
10-5
0.00 + 0.00
-6
10
0.00 + 0.00
10-3
0.55 + 0.03
-4
10
0.66 + 0.36
E. faecalis
-5
10
0.25 + 0.18
10-6
1.27 + 1.87
-3
10
0.00 + 0.00
10-4
0.00 + 0.00
E. coli
-5
10
0.00 + 0.00
10-6
0.00 + 0.00
-3
10
0.01 + 0.01
-4
10
0.00 + 0.00
M. luteus
10-5
0.00 + 0.00
-6
10
0.00 + 0.00
10-3
0.00 + 0.00
-4
10
0.00 + 0.00
B. subtilis
10-5
0.00 + 0.00
-6
10
0.00 + 0.00
-3
10
1.87 + 0.00
S. intermedius
10-4
0.67 + 0.00
-5
10
0.00 + 0.00
10-3
0.05 + 0.03
-4
10
0.05 + 0.01
S. simulans
10-5
0.17 + 0.12
-6
10
0.00 + 0.00
-3
10
2.03 + 0.00
S. chromogenes
10-5
0.00 + 0.00
-6
10
0.00 + 0.00
10-3
1.48 + 0.00
-5
S. haemolyticus
10
0.00 + 0.00
10-6
0.00 + 0.00
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Anti-Protein A Specificity for S. aureus in Pure Culture
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Figure 24. Anti-Protein A specificity for S. aureus in pure culture. Sa refers to S. aureus 6538,
Bs refers to B. subtilis, Ef refers to E. faecalis, Ec refers to E. coli, Ml refers to M. luteus, Se
refers to S. epidermidis, Si refers to S. intermedius, Ss refers to S. simulans, Sp refers to S.
pyogenes, Sc refers to S. chromogenes, and Sh refers to S. haemolyticus. For each bacteria
strain, average bacteria inputs were calculated (CFU/ml): S. aureus 3.81 x 109 CFU/ml, B.
subtilis 6.04 x 109 CFU/ml, E. faecalis 1.18 x 109 CFU/ml, E. coli 1.04 x 109 CFU/ml,, M. luteus
1.06 x 109 CFU/ml, S. epidermidis 2.21 x 109 CFU/ml, S. intermedius 7.47 x 108 CFU/ml, S.
simulans 1.15 x 109 CFU/ml, S. pyogenes 3.07 x 107 CFU/ml. S. chromogenes 4.86 x108
CFU/ml and S. haemolyticus 4.20 x 108 CFU/ml. Statistical significance (P-value) was
determined by comparing results of each negative control strain to S. aureus. One asterisk (*)
denotes a P-value less than 0.001.

Analysis of S. aureus isolation from whole milk
To determine anti-Protein A DynaBeads ability to capture S. aureus from whole
milk, capture efficiencies were calculated for S. aureus, B. subtilis, L. monocytogenes,
and DynaBeads alone. Initial inputs of the bacteria were also determined in order to
calculate capture efficiencies. The whole milk alone was also plated out in order to
determine the concentration of naturally occurring bacteria within the milk (Figure 25).
Whole milk alone typically contains multiple Bacillus species, Lactobacillus species, and
Streptococcus species. S. aureus is rarely found in Pasteurized milk from healthy
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animals; however, animals with mammary glands infected by S. aureus can lead to milk
contamination 26. To determine if S. aureus could be captured with anti-Protein A
DynaBeads from a complex biological fluid like whole milk, 50 µl of an overnight
culture of S. aureus was initially mixed with 450 µl of whole milk (10-1 dilution). This
sample was then used to make further 10-fold dilutions down to 10-6. Twenty microliters
of anti-Protein A DynaBeads were added to the 10-3, 10-5, and 10-6 dilutions, then
processed as described above to assess capture efficiencies.
Capture efficiencies within whole milk displayed reduced efficiency for S. aureus
compared to capture in TSB media (Table 5). In whole milk, S. aureus capture efficiency
was 54.89% + 5.78, while negative controls B. subtilis and L. monocytogenes capture
efficiencies were both 0.00% + 0.00. DynaBeads alone (not bound to anti-Protein A
antibodies) were also added to samples containing S. aureus, B. subtilis, and L.
monocytogenes where they displayed 0.00% + 0.00 capture efficiencies in all samples
(Table 5, Figure 26 and 27). Statistical analysis using one-way ANOVA Bonferroni
multiple comparison test displayed significance with a P-value less than 0.001 when
comparing the capture efficiencies of B. subtilis to S. aureus, L. monocytogenes to S.
aureus, and DynaBeads alone to S. aureus.
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Figure 25. Naturally occurring bacteria from whole milk. Naturally occurring bacteria
contaminants found within pasteurized whole milk. Performed in duplicate, 10-fold dilutions
of pure whole milk were generated and 100 µl of a 10-6 dilution was spread plated on TSB agar
and incubated at 37 ͦ C for 18 hours. (A) Naturally occurring bacteria from pasteurized whole
milk performed (B) performed in duplicate from separate milk sources. Bacterial strain
variation displayed between the two milk sources.
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Figure 26. Specificity of anti-Protein A antibodies for S. aureus alone in pure culture of
whole milk. 100 µl of 10-6 dilution was spread plated of bound anti-Protein A DynaBeads.
(A) S. aureus input without anti-Protein A DynaBeads. (B) S. aureus captured from milk by
anti-Protein A DynaBeads. (C) S. aureus combined with DynaBeads alone in milk (D) L.
monocytogenes input without anti-Protein A DynaBeads. (E) L. monocytogenes captured
from milk by anti-Protein A DynaBeads. (F) L. monocytogenes combined with DynaBeads
alone (G) B. subtilis input without anti-Protein A DynaBeads. (H) B. subtilis captured from
milk by anti-Protein A DynaBeads (I) B. subtilis combined with DynaBeads alone.
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Table 6. Average capture efficiencies of S. aureus from pasteurized whole milk.
Organism
S. aureus

B. subtilis

L. monocytogenes

DynaBeads alone

Dilution
10-3
10-5
10-6
10-3
10-5
10-6
10-3
10-5
10-6
10-3
10-5
10-6

Average Capture Efficiency (%)
57.53 + 3.87
57.53 + 3.87
49.62 + 7.32
0.00 + 0.00
0.00 + 0.00
0.00 + 0.00
0.00 + 0.00
0.00 + 0.00
0.00 + 0.00
0.00 + 0.00
0.00 + 0.00
0.00 + 0.00

Average Caputre Efficiency (%)
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Figure 27. Average capture efficiencies (%) of S. aureus 6538 and negative control strains in
whole milk and for each bacteria strain, average bacteria inputs were calculated (CFU/ml). S.
aureus capture efficiency of 54.89% + 5.78 with an initial input of 5.54 x 109 CFU/ml, B.
subtilis capture efficiency of 0.00% + 0.00 with an initial input of 7.22 x 108 CFU/ml, and L.
monocytogenes with a capture efficiency of 0.00% + 0.00 with an initial input of 2.44 x 109
CFU/ml. Statistical significance (P-value) was determined by comparing results of each
negative control strain to S. aureus. One asterisk (*) denotes a P-value less than 0.001.

76

DISCUSSION

Due to anti-Staph DynaBeads lack of capture specificity for S. aureus, antiProtein A antibodies were chosen in order to aid in increasing capture efficiency rate for
S. aureus and reduce the rate of non-specific binding of negative controls. Protein A is
expressed on the surface of nearly all S. aureus strains and occupies approximately 7% of
the S. aureus cell surface 30. By utilizing an antibody that is specific to a S. aureus
surface protein rather than against whole S. aureus cells (anti-Staph DynaBeads), we
hoped to increase the specificity of capture and reduce non-specific binding. Prior to the
use of anti-Protein A DynaBeads, we needed to develop IMS methods for the greatest
recovery of S. aureus cells. To develop anti-Protein A IMS methods, we needed to
determine if the wash buffer altered non-specific binding of bacteria to the walls or cap of
microcentrifuge tubes, or the DynaBeads themselves. The following media types were
utilized in the washing process and evaluated for efficiency: PBS, PBS + 0.1% BSA, and
PBS + 0.01% Tween 20. PBS is a balanced salt solution used for a variety of cell culture
applications including washing cells 70. BSA is commonly used to reduce non-specific
hydrophobic binding and Tween 20 has been used as a blocking agent in immunoassays
73,85

. The addition of a 0.1% of either BSA or 0.01% Tween 20 to PBS was evaluated for

its effect on non-specific binding.
The first comparison of media wash efficiency was done by evaluating PBS and
PBS + 0.1% BSA. Anti-Protein A DynaBeads were added to pure cultures of S. aureus,
mixed for one hour to induce capture and then washed 4 times with either PBS or PBS +
0.1% BSA. After the washing process, the samples were spot plated on TSB agar and
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incubated at 37 ͦ C for 18 hours. Figure 18 shows that there is not a significant difference
between the capture rate when using either PBS or PBS + 0.1% BSA. To determine if
non-specific binding was the cause of S. aureus capture, rather than actual anti-Protein A
capture, DynaBeads alone were added to pure cultures of S. aureus, mixed for one hour
to induce capture and then washed 4 times with either PBS or PBS + 0.1% BSA. After
the washing process, the samples were spot plated on TSB agar and incubated at 37 ͦ C for
18 hours. Figure 18 showed no non-specific binding when using PBS as a wash buffer,
while PBS + BSA displayed minimal non-specific capture.
To further analyze wash buffer efficiency, non-specific binding between PBS was
then compared to PBS + 0.01% Tween 20. To evaluate PBS and PBS + Tweens ability to
reduce non-specific binding, DynaBeads alone were added to samples containing S.
aureus and mixed for one hour to induce capture and then washed 4 times with either
PBS or PBS + 0.01% Tween. When washed with PBS alone, the DynaBeads alone (nonspecific binding) displayed an average capture efficiency of 0.83% + 0.41. When washed
with PBS + 0.01% Tween, the DynaBeads alone (non-specific binding) displayed an
average capture efficiency of 0.17% + 0.13. Although there was not a significant
difference in non-specific binding, we decided to utilize PBS + 0.01% Tween in order to
reduce as much non-specific binding within a sample as possible.
Upon the development of IMS methods for S. aureus capture, the specificity of
anti-Protein A DynaBeads for S. aureus in pure culture was next evaluated. Both capture
efficiencies of S. aureus and non-specific binding of negative controls were calculated
and statistical significance was determined by one-way ANOVA Bonferroni multiple
comparison test. By performing this set of experiments we wanted to determine if anti-
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Protein A DynaBeads had specificity for S. aureus compared to negative controls. We
utilized a wide variety of negative controls to represent organisms that may be found in
naturally occurring swab specimens including: M. luteus, S. pyogenes, and S. epidermidis
which represent normal skin microbes. E. faecalis, which can sometimes be found in skin
ulceration with S. aureus. E. coli, a Gram-negative gut microbe containing pili on its cell
surface, was also utilized as a negative control to challenge our IMS methods 41.
Utilizing IMS with anti-Protein A DynaBeads resulted an average S. aureus capture
efficiency of 82.00% of the initial input of cells. Comparing the capture efficiency of S.
aureus to other normal flora negative controls (M. luteus, S. pyogenes, E. faecalis and S.
epidermidis) and E. coli, the negative control strains were captured on average less than
1.00% and statistical significance was displayed with P-value less than 0.001 (Table 5,
Figure 24).
S. simulans and S. intermedius were also utilized to test the specificity of the antiProtein A DynaBeads specificity for capturing S. aureus. As previously mentioned,
Protein A is a surface protein specific to S. aureus. However, after conducting a BLAST
search of S. aureus Protein A (Table 1), it was determined that a limited number of other
Staphylococcus species also contain a protein with some homology to S. aureus Protein
A. To determine if our antibody was specific to S. aureus Protein A, S. intermedius (61%
Percent Identity to S. aureus Protein A) and S. simulans (34% Percent Identity to S.
aureus Protein A) were utilized as negative controls. Comparing the average capture
efficiency of S. aureus (82.00%) to the capture efficiencies of Protein A containing
Staphylococcus strains, S. intermedius and S. simulans both had average capture
efficiencies less than 1.00% (Table 5, Figure 24). These results display statistically
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significant evidence to suggest that anti-Protein A DynaBeads have specificity for S.
aureus.
To test anti-Protein A DynaBead specificity for S. aureus in a complex biological,
IMS methods were performed in pasteurized whole milk and capture efficiencies for S.
aureus and other negative controls were determined. Milk related pathogens include:
Salmonella, E. coli, Listeria, and Staphylococcus 16. Non-pathogenic strains such as
Streptococcus, Bacillus, and Lactobacillus can also be found in milk samples even after
Pasteurization 72. Figure 25 displays the naturally occurring bacteria that were found
specifically in our Pasteurized whole milk which included Lactobacillus, Streptococcus,
and Bacillus species. For our negative control strains we chose L. monocytogenes and B.
subtilis. L. monocytogenes is commonly responsible for dairy related food-poisoning and
B. subtilis has also been found to be an environmental contaminant in milk 25,72. As
described above, IMS methods were performed in whole milk and capture efficiencies
and statistical significance was calculated for S. aureus and negative controls. After IMS
methods were performed, S. aureus capture efficiency was 54.89% + 5.78, B. subtilis
capture efficiency was 0.00% + 0.00, and L. monocytogenes capture efficiency was
0.00% + 0.00 (Table 6, Figure 27). When comparing the capture efficiencies of S. aureus
to both negative controls, we observed statistical significance with a P-value less than
0.001 (Figure 27). DynaBeads alone were also added to samples containing each of the
above mentioned bacteria. There was no non-specific binding, further supporting the
efficiency of our IMS washing method with PBS containing 0.01% Tween (Table 6,
Figure 26).
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In conclusion, anti-Protein A DynaBeads displayed significant specificity for S.
aureus in both pure culture and when isolated from whole milk. In pure culture, IMS
capture efficiency was 82% compared to 54% in whole milk. Although S. aureus was
captured in whole milk, we hypothesized that there would be a reduction in recovery rate
due to the complexity of the fluid and the increased rate of competing cells and particles.
If IMS methods were to be performed in whole milk in the future, increasing the
capture/binding time of anti-Protein A DynaBeads from 1 hour to 2 hours could
potentially lead to an increase in capture efficiency for S. aureus.
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CHAPTER FIVE: COMBINING IMMUNOMAGNETIC SEPARATION AND
SINGLE LASER-LIGHT SCATTERING FOR RAPID IDENTIFICATION

INTRODUCTION
In the previous chapter, protocol for IMS of S. aureus utilizing anti-Protein A
DynaBeads was established. Following S. aureus capture, an enrichment step needed to
be developed in order to obtain a concentration of bacteria high enough for laser-light
scattering identification (which is approximately 1,000 bacteria cells per milliliter) 37. To
determine the optimal conditions for enrichment, variables were altered in order to
determine optimal conditions for the IMS of S. aureus and identification via laser-light
scattering. Variables that were altered included: media volume, media filtration versus
non-filtered media, enrichment duration, and sample aeration (200-300 rpm), and
incubation.
A protocol was established for anti-Protein A DynaBead S. aureus capture,
enrichment of bacteria, and subsequent identification via laser-light scattering. Following
the development of this protocol, the ability to capture, enrich, and identify S. aureus via
laser-light scattering was tested on S. aureus and the negative control strains (S.
pyogenes, M. luteus, E. faecalis, L. monocytogenes, E. aerogenes, and E. coli). In order to
evaluate its specificity for S. aureus, S. aureus was measured alone or mixed with
negative controls to create a more complex and realistic specimen sample. The capture
efficiency and accuracy of the rapid identification methods were then assessed. Percent
identified as Staphylococcus species was calculated and statistical significance was
determined by a one-way ANOVA Bonferroni multiple comparison test.
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In typical wound infection and skin/soft tissue infections, specimens are collected
from these types of infection sites on sterile swabs. In order to determine if IMS could
successfully capture S. aureus from a swab sample, we inoculated sterile swabs with a
broth culture containing dilutions of S. aureus. The swabs were transferred to a test tube
containing TSB growth media. The previously established capture, enrichment, and
identification protocol was used to isolate the bacteria from swab specimens. Since S.
aureus is not always isolated in pure culture from the site of infection, we created mixed
swab samples to replicate a sample containing normal skin microorganisms. S. aureus
were combined with S. pyogenes, M. luteus, and S. epidermidis and the previously
mentioned methods were repeated. To further assess our developed methods, bacteria
taken from healthy human skin and nose swabs were mixed with S. aureus. The use of
bacteria from human swab samples (likely containing multiple bacterial species) allowed
us to increase the complexity of the samples and replicate a mixture of microbes that
might be seen from an actual infection site. This set of experiments allowed us to assess
if our IMS and laser-light scattering identification methods can be utilized on complex
biological samples. Finally, in order to determine the amount of bacteria that grows
within a sample during the enrichment stage over time, samples were magnetically
separated after each hour for five hours. The average growth (CFU/ml) by enrichment
over a 5 hour time frame from swab specimen collection was determined in order to
quantify the number of progeny produced during the enrichment step. To calculate this,
after IMS capture, each hour, the tubes were magnetically separated for 3 minutes and the
supernatant was spread plated on TSB agar and incubated at 37 ͦ C for 18 hours. Colony
forming units were then calculated.
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METHODS

IMS capture, enrichment, and laser-light scattering identification
Development of IMS capture, enrichment, and laser-light scattering identification
methods
Once anti-Protein A DynaBeads specificity was been established for S. aureus, an
enrichment step needed to take place in order to obtain the proper concentration of
bacteria for laser-light scattering identification (approximately 1,000 bacteria cells per
milliliter) 37. To determine the optimal conditions for enrichment 10-fold serial dilutions
from overnight cultures (10-3 to 10-8) were utilized to represent different concentrations of
the bacteria that could be obtained in a clinical sample. Variables that were altered in
order to determine optimal conditions for IMS and laser-light scattering identification
protocol occurred during each step of the protocol. During IMS protocol the temperature
(22 ͦ C and 37 ͦ C) during IMS binding was tested for effects on binding efficiency.
Enrichment step variables altered included: growth media volume, filtered versus nonfiltered media, enrichment duration, and sample aeration (200-300 rpm). MIT sample
preparation variables altered included: (1) directly testing bacteria resuspended in filtered
TSB growth media or (2) testing bacteria resuspended in filtered water after pelleting the
capture cells and removing TSB growth media. We also tested if DynaBead removal,
after the enrichment step and prior to laser-light scattering identification, would increase
the accuracy of identification since DynaBeads are small particles that could interfere
with laser-light scattering measurements.
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In order to determine optimal conditions, the previously establish IMS protocol
was used with the exception of a temperature change during binding from 22 ͦ C to 37 ͦ C.
After washing the 20 µl of conjugated anti-Protein A DynaBeads bound to S. aureus in
the sample, the DynaBeads were resuspended in 25-50 µl of either non-filtered TSB or
filtered TSB liquid media (Thermo Scientific Nalgene vacuum filtration system, 0.2
micron filter) and transferred into sterile microcentrifuge tubes. The tube transfer limited
the unwanted transfer of unbound cells that could be stuck on the sides/tops of the tubes.
After the transfer, the tubes were incubated at 37◦C for 1-5 hours. Each hour the tubes
were magnetically separated for a minimum of 3 minutes. MIT sample preparation was
either conducted by either directly testing about 1.0 µl of the supernatant from the media
or by pelleting the cells within the sample (centrifuging for 1 minute at top speed),
removing the liquid media and resuspending the cells in filtered water before testing in
the MIT 1000. The optimal time for enrichment and the optimal bacterial concentrations
were evaluated for accurate identification of S. aureus using laser-light scattering
analysis. The final variable evaluated during MIT sample preparation was the addition of
one 150 µl filtered water wash after pelleting and removing the media. All of the above
mentioned variables were adjusted one at a time in order to establish IMS capture,
enrichment, and laser-light scattering identification methods for rapid S. aureus detection.
IMS capture, enrichment, and laser-light scattering identification (established
methods)
Fifty microliters of bacterial specimens from overnight cultures were 10-fold
serial diluted (10-2 to10-6) in 450 µL of TSB, 20 µL of the anti-Protein A DynaBeads
were added to the specimens and rotated for 1 hour at 37 ͦ C. The samples were then
magnetically separated for 3 minutes, the TSB was removed and anti-Protein A
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DynaBeads were resuspended in 450 µL of PBS plus 0.01% Tween 20. The samples
were then rotated for 1 minute at room temperature and then magnetically separated for 3
minutes. This process was repeated for a total of 4 washes. The anti-Protein A
DynaBeads were then transferred into a sterile microcentrifuge tubes with 50 µL of PBS.
The transfer liquid (PBS) was then removed and the DynaBeads were resuspended in 50
µl of filtered TSB.
The bacteria captured by the anti-Protein A DynaBeads were enriched in 50 µL of
filtered TSB. The surface tension of each sample was broken and the tubes were shaken
at 250 rpm and incubated at 37 ͦ C for 5 hours. The samples were vortexed for 20-30
seconds and magnetically separated for 3 minutes. The supernatant was removed and
transferred to a new microcentrifuge tube. This step was performed in order to reduce
DynaBead transfer, which may interfere with laser-light scattering measurements. The
supernatant was pelleted (centrifuged for 1 minute at 14000 rpm) and the media was
removed. The pellet was then washed with 150 µL of filtered water, vortexed to break up
the pellet and centrifuged for 1 minute at top speed. The filter water was then removed
and the pelleted bacteria is then ready for laser-light scattering analysis. Filtered water
(10-50 µL) was then added to the prepared sample, vortexed for 20-30 seconds and
magnetically separated for 3 minutes. A portion of the sample was loaded into a prepared
water vial and a laser-light scattering identification analysis is conducted.
Rapid laser-light scattering identification from IMS samples (experiment)
In order to determine the efficiency of the established IMS laser-light scatting
rapid identification methods, the procedure was tested on both S. aureus and the negative
control strains (S. pyogenes, M. luteus, E. faecalis, L. monocytogenes, E. aerogenes, and
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E. coli) in order to evaluate its specificity for S. aureus alone. Using previously
established methods, bacterial strains alone were 10-fold serial diluted from overnight
cultures in duplicate and anti-Protein A DynaBeads were added to each dilution (10-2 10-6) of one set of the serial dilutions. The other set of serial dilutions were utilized for
counting the initial input of bacteria into each sample. To determine the initial input for
each sample, each tube was vortexed for 10 seconds to resuspend the bacteria in the tube
and 100 µl was spread plated on TSB agar plates and incubated at 37 ͦ C for 18 hours
(performed in triplicate). Colony forming units per milliliter (CFU/ml) were calculated
for each tube. The samples containing DynaBeads went through the established IMS and
enrichment protocol and were then tested in the MIT 1000 for laser-light scattering
identification. The same methods were then utilized in order to perform combination
challenges between S. aureus and equal concentrations of the negative controls (S. aureus
and S. pyogenes, S. aureus and M. luteus, S. aureus and E. faecalis, S. aureus and L.
monocytogenes, S. aureus and E. aerogenes, S. aureus and E. coli). Combination
challenges utilizing S. aureus and two negative controls were also utilized (S. aureus, S.
pyogenes, and M. luteus AND S. aureus, S. pyogenes, and E. coli).
IMS capture, enrichment, and laser-light scattering identification from swab
specimens
Swab specimen collection technique
Swab specimen collection protocol was attained and altered from Panpradist et al.
2014. Ten-fold serial dilutions (10-2 to 10-6) of S. aureus overnight cultures were
generated from overnight cultures in TSB growth media. Swabs (Sterile polyester tipped
applicator swabs, VWR) were submerged in initial serial dilutions for 10 seconds. Swabs
were then submerged in a transfer microcentrifuge tube containing 450 µl of filtered
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TSB. To translate the obtained bacteria to the new microcentrifuge tubes, the submerged
swabs were dragged along the edge of the tube in a circular path at a rate of 1 cycle per
second (1 HZ) for 10 seconds (10 second 1 HZ side twirl). The swab agitation was done
by hand utilizing the timer as a reference for manual control of transfer time 68.
Development of IMS capture, enrichment, and laser-light scattering identification for
swab specimens
The most common types of S. aureus infections in humans are skin infections,
wound infections, and abscesses 55 14. Specimens are typically collected from these types
of infection sites on sterile swabs. In order to demonstrate that our developed IMS
capture methods could successfully capture S. aureus from swab samples, we inoculated
sterile swabs with a broth culture containing dilutions (10-2 to 10-6) of S. aureus. The
swabs were transferred to a test tube containing growth media and vortexed to dislodge
the bacterial cells from the swab to create a suspension. To capture the bacteria in the
sample, swabs were removed and 10-20 µl of anti-Protein A DynaBeads were added to
the tubes. Previously established IMS protocol was used to isolate the bacteria from
swab specimens. The MIT instrument then measured the laser-light scattering pattern of
the bacteria in the sample and determine the bacteria matches the known Identifier for
Staphylococcus species (or S. aureus or MRSA when those Identifiers become available).
Since S. aureus is not always isolated in pure culture from the site of infection, we then
created mixed swab samples to replicate normal skin microorganisms. S. aureus was then
combined with S. pyogenes, M. luteus, and S. epidermidis and the previously mentioned
methods were be repeated.
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Rapid bacterial identification from IMS swab samples (established protocol)
Bacterial strains were grown in TSB at 37 ͦ C for 18-24 hours. Serial dilutions of
cultures in filtered TSB (0.2 micron filter) were produced for IMS and MIT laser-light
scattering identification testing. Serial dilutions were made in low-binding polymer
microcentrifuge tubes (Life Technologies).
Bacterial specimens were obtained from 10-fold serial dilutions of overnight
cultures via swab collection. Swab collections (10 seconds) were transferred into a
microcentrifuge tube with 450 µL of filtered TSB. 20 µL of the anti-Protein A
DynaBeads were added to the swab collected specimens and rotated for 1 hour at 37 ͦ C.
The samples were then magnetically separated for 3 minutes, the filtered TSB was
removed and the anti-Protein A DynaBeads were resuspended in 450 µL of PBS plus
0.01% Tween 20. The samples were then rotated for 1 minute at room temperature and
then magnetically separated for 3 minutes. This process was repeated for a total of 4
washes. The anti-Protein A DynaBeads were then transferred into natural microcentrifuge
tubes with 50 µL of filtered TSB.
Anti-Protein A DynaBeads were enriched in 50 µL of filtered TSB. The surface
tension of each sample was broken and the tubes were shaken at 250 rpm and incubated
at 37 ͦ C for 5 hours. The samples were vortexed for 20-30 seconds and magnetically
separated for 3 minutes. The supernatant was removed and transferred to a new
microcentrifuge tube. The supernatant was pelleted (centrifuged for 1 minute at top speed
14000 rpm) and the media was removed. The pellet was then washed with 150 µL of
filtered water, vortexed to break up the pellet and centrifuged for 1 minute at top speed.
The filter water was then removed and the pelleted bacteria was resuspended in 10-50 µl
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of filter water, vortexed for 20-30 seconds and magnetically separated for 3 minutes. A
portion of the sample (about 1 µl) was loaded into a prepared water vial and a MIT laserlight scattering identification test was conducted using previously mentioned MIT sample
protocol.
Rapid bacterial identification from IMS swab samples (experiment)
In order to determine the accuracy of the established IMS and laser-light
scattering identification swab methods, the procedure was tested on both S. aureus and
the negative control strains (S. pyogenes, M. luteus, E. faecalis, L. monocytogenes, E.
aerogenes, and E. coli) in order to evaluate its specificity for S. aureus alone. Using
previously established IMS swab methods, bacterial strains alone were 10-fold serial
diluted from overnight cultures in duplicate and the specimens were obtained by swabs,
and dislodged into microcentrifuge tubes containing 450 µl of growth media, and 20 µl of
anti-Protein A DynaBeads were added to each 10-fold dilution (10-2 - 10-6) of one set of
the serial dilutions. The other set of serial dilutions were utilized for counting the initial
input of bacteria into each sample. To determine the initial input for each sample, each
tube was vortexed for 10 seconds to resuspend the bacteria in the tube and 100 µl was
spread plated on TSB agar plates and incubated at 37 ͦ C for 18 hours (performed in
triplicate). Colony forming units per milliliter (CFU/ml) were calculated for each tube.
The samples containing DynaBeads went through the established IMS swab protocol and
were tested in the MIT 1000 for laser-light scattering identification.
The same methods were then utilized to capture and identify S. aureus in a mixed
swab sample containing equal amounts of S. aureus and one negative control. The
pairings were S. aureus and S. pyogenes, S. aureus and M. luteus, S. aureus and E.
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faecalis, S. aureus and L. monocytogenes, S. aureus and E. aerogenes, S. aureus and E.
coli. Combination challenges containing S. aureus and two negative controls were also
utilized (S. aureus, S. pyogenes, and M. luteus AND S. aureus, S. pyogenes, and E. coli).
Rapid S. aureus identification following IMS of samples containing mixed human nose
and skin microflora
Nose swabs were collected by first soaking the sterile swab in 0.9% saline
solution. The swab was then inserted approximately 2 cm (~3/4 inches) into one nostril.
The swab was then rotated against the anterior nasal mucosa for 10 seconds. The
obtained specimen was then transferred into a microcentrifuge tube containing 450 µl of
TSB media. Skin swabs were collected by first soaking the sterile swab in a 0.9% saline
solutions. The swab was the rubbed against the inner forearm skin in a 2” x 2” square for
10 seconds. The obtained specimen was then transferred into a microcentrifuge tube
containing 450 µl of TSB media. To the obtained swab samples, 50 µl of a S. aureus
overnight culture was added and the existing swab IMS protocol, enrichment, and MIT
laser-light scattering identification was conducted. This procedure was tested on the
following samples: (1) skin swab and S. aureus, (2) nose swab and S. aureus, (3) skin,
nose and S. aureus, (4) nose swab alone, (5) skin swab alone, and (6) an overnight of a
direct nose swab.
Calculation of average bacteria growth by enrichment over time
The average growth (CFU/ml) by enrichment over a 5 hour time frame from swab
specimen collection was determined in order to quantify the number of progeny produced
during the enrichment step. To calculate this, 10-fold serial dilutions of a S. aureus
overnight culture were created and 20 µl anti-Protein A DynaBeads were added to each
dilution (10-3 to 10-6). Using previously established IMS methods, S. aureus cells
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captured by anti-Protein A DynaBeads were resuspended in filtered TSB agar and
incubated at 37 ͦ C for 5 hours while shaken at 250 rpm. Each hour, the tubes were
vortexed for 10 seconds, magnetically separated for 3 minutes, and the supernatant (50
µl) was spread plated on TSB agar and incubated at 37 ͦ C for 18 hours. Colony forming
units were then calculated.
Calculation of capture efficiencies and statistical analysis
Capture efficiencies (CE) are defined as the percentage fraction of total bacteria
captured on the surface of the anti-Protein A DynaBeads 90. Capture efficiencies are
calculated using the number of unbound cells in the starting dilution (input). The equation
for Capture efficiency is calculated using the following equation: Capture efficiency(%)
= (1-B/A) x 100% 90. A is the total number of cells present in the sample (CFU/ml) and
B is the number of cells unbound to the anti-Protein A DynaBeads (CFU/ml, input).
Statistical analysis of capture efficiencies and MIT laser-light scattering identifications
were performed with Prism 3 program (GraphPad Software, Inc.). Statistical significance
was measured by one-way ANOVA utilizing Bonferroni multiple comparison test.
Statistical significance was defined with a P-value less than 0.05 when comparing
negative control strains to positive control S. aureus 6538. A P-value greater than 0.05
indicated that there was no statistical significance between capture efficiencies and laserlight scattering results when comparing negative controls to S. aureus 6538.
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RESULTS

Development of IMS capture, enrichment, and rapid identification by laser-light
scattering
In order to determine the optimal conditions for post-IMS rapid identification of
S. aureus by laser-light scattering, various conditions were evaluated for their effects on
successful identification. The following variables were altered: media type for
enrichment, filtration of media for enrichment, removal of DynaBeads during
enrichment, time of enrichment, removal of growth media after enrichment, and
resuspension of captured bacteria in filtered water. Percent identification as
Staphylococcus species under set conditions were evaluated and a one-way ANOVA
Bonferroni multiple comparison test was conducted in order to determine statistical
significance.
Figure 28 displays the results of S. aureus laser-light identification analysis under
varying conditions. The no bead removal section of Figure 28 protocol was performed as
indicated in the methods section with the following modifications: samples were bound in
filtered TSB media at 22 ͦ C, 1-3 hours of enrichment in filtered TSB at 37 ͦ C, and
magnetic separation of anti-Protein A DynaBeads and direct addition of supernatant to
MIT vials for laser-light scattering analysis. These variables resulted in S. aureus
identifying as Staphylococcus species in 30% of samples. The shaken at 215 rpm section
of Figure 28 protocol was as follows: IMS methods performed in filtered TSB media at
22 ͦ C, 1-3 hours of enrichment in filtered TSB while shaken at 215 rpm at 37 ͦ C,
magnetic separation of anti-Protein A DynaBeads and direct addition of supernatant to
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MIT vials for laser-light scattering analysis. These conditions resulted in S. aureus
identifying as Staphylococcus species in 45% of samples. The incubated binding section
of Figure 28 protocol was as follows: IMS methods performed in filtered TSB media at
37 ͦ C, 1-3 hours of enrichment in filtered TSB while shaken at 215 rpm at 37 ͦ C,
magnetic separation of anti-Protein A DynaBeads and direct addition of supernatant to
MIT vials for laser-light scattering analysis. Under these conditions, S. aureus identified
as Staphylococcus species in 36% of samples. The shaken at 250 rpm section of Figure
28 protocol was as follows: IMS methods performed in filtered TSB media at 37 ͦ C, 1-3
hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, magnetic
separation of anti-Protein A DynaBeads and direct addition of supernatant to MIT vials
for laser-light scattering analysis. These conditions resulted in S. aureus identifying as
Staphylococcus species in 44% of samples. The bead removal section of Figure 28
protocol was as follows: IMS methods performed in filtered TSB media at 37 ͦ C, 1-2
hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, after 1-2 hours of
enrichment, anti-Protein A DynaBeads were removed and the enrichment incubation of
samples resumed, magnetic separation of anti-Protein A DynaBeads and direct addition
of supernatant to MIT vials for laser-light scattering analysis. S. aureus identified as
Staphylococcus species in 64% of samples. The Terrific broth section of Figure 28
protocol was as follows: IMS methods performed in filtered Terrific broth media at 37 ͦ C,
1-3 hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, after 1-2 hours
of enrichment, anti-Protein A DynaBeads were removed and the enrichment incubation
of samples resumed, magnetic separation of anti-Protein A DynaBeads and direct
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addition of supernatant to MIT vials for laser-light scattering analysis. Under these
conditions, S. aureus identified as Staphylococcus species in 50% of samples.
The optimal conditions protocol was established as follows: IMS methods were
performed in filtered TSB media at 37 ͦ C, 1-5 hours of enrichment in filtered TSB while
shaken at 250 rpm at 37 ͦ C, after enrichment anti-Protein A DynaBeads were removed
and so was the TSB media (by pelleting the cells in the supernatant), S. aureus cells were
then resuspended in filtered water, vortexed (to break up the pellet) and samples were
then added to MIT vials for laser-light scattering analysis. When these conditions were
utilized, S. aureus identified as Staphylococcus species in 80% of samples (Figure 28).
After statistical analysis using a one-way ANOVA Bonferroni multiple comparison test,
P-values were greater than 0.05 for all conditions when compared to the established
optimal conditions. This displayed no statistical significant difference between any of the
conditions; however, when optimal conditions were utilized to identify S. aureus as
Staphylococcus species via laser-light scattering, 80% of the samples identified
accurately.
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Figure 28. Analysis of IMS and MIT optimal conditions. IMS and MIT conditions were
altered in order to determine the optimal conditions for the highest percent identified as
Staphylococcus species for S. aureus. No bead removal resulted in S. aureus identifying as
Staphylococcus species in 30% of samples. When samples were shaken at 215 rpm this
resulted in S. aureus identifying as Staphylococcus species in 45% of samples. When the
samples were incubated during anti-Protein A DynaBead binding at 37 ͦ C, S. aureus
identified as Staphylococcus species in 36% of samples. When samples were shaken at 250
rpm this resulted in S. aureus identifying as Staphylococcus species in 44% of samples. When
anti-Protein A DynaBeads were removed after 1-2 hours of enrichment, S. aureus identified
as Staphylococcus species in 64% of samples. When IMS and MIT methods were performed
in filtered Terrific Broth, rather than filtered TSB, S. aureus identified as Staphylococcus
species in 50% of samples. Optimal conditions included the removal of anti-Protein A
DynaBeads and removal of enrichment media after 5 hours of enrichment; when these
conditions were utilized, S. aureus identified as Staphylococcus species in 80% of samples.

Analysis of rapid laser-light scattering detection from pure IMS samples
Upon the establishment of IMS, enrichment, and laser-light scattering
identification methods, identification of S. aureus was then evaluated in both pure S.
aureus culture samples and mixed bacteria cultures (Figures 29 and 30). Percent
identified as Staphylococcus species from pure cultures displayed with an average initial
input of 4.86 x 109 CFU/ml, S. aureus identified as Staphylococcus species via laser-light
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scattering 80% of the time. With an average initial input of 3.97 x 109 CFU/ml, M. luteus
falsely identified as Staphylococcus species via laser-light scattering 12.5% of the time.
E. aerogenes with an average initial input of 2.15 x 108 CFU/ml, E. coli with an average
initial input of 4.46 x 108 CFU/ml, E. faecalis with an average initial input of 1.75 x 109
CFU/ml, L. monocytogenes with an average initial input of 2.60 x 109 CFU/ml, and S.
pyogenes with an average initial input of 5.60 x 108 CFU/ml all identified as
Staphylococcus species via laser-light scattering 0.00% of the time. Statistical analysis
via one-way ANOVA Bonferroni multiple comparison test displayed P-values of less
than 0.001 for all negative control strains when comparing the results of percent
identified as Staphylococcus species of each negative control strain to percent identified
as Staphylococcus species for S. aureus.
In order to determine percent identified as Staphylococcus species from mixed
samples, multi-microbial samples were generated in order to replicate more realistic
clinical samples that are often polymicrobial. When in pure culture, S. aureus identified
as Staphylococcus species via laser-light scattering 80% of the time with an initial input
of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes with an initial input, 2.15 x 108 CFU/ml
identified as Staphylococcus species via laser-light scattering 50% of the time. S. aureus
+ E. coli with an initial input of 4.46 x 108 CFU/ml identified 0% of the time. S. aureus +
E. faecalis with an initial input of 1.75 x 109 CFU/ml identified 50% of the time. S.
aureus + L. monocytogenes with an initial input, 2.60 x 109 CFU/ml identified 60% of the
time. S. aureus + M. luteus with an initial input of 3.98 x 109 CFU/ml identified 75% of
the time. S. aureus + S. pyogenes with an initial input of 5.60 x 108 CFU/ml identified
75% of the time. S. aureus + S. pyogenes + M. luteus identified 75% of the time. S.
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aureus + S. pyogenes + E. coli identified 0% of the time. Statistical analysis via one-way
ANOVA Bonferroni multiple comparison test displayed P-values of less than 0.05 when
comparing the results of percent identified as Staphylococcus species of S. aureus with
multi-microbial samples containing E. coli. Specifically, when S. aureus was mixed with
E. coli and when S. aureus was mixed with E. coli and S. pyogenes P-values were less
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Figure 29. Percent identified as Staphylococcus species from pure samples. S. aureus
identified as Staphylococcus species via laser-light scattering 80% of the time with an initial
input of 4.86 x 109 CFU/ml. M. luteus identified as Staphylococcus species via laser-light
scattering 12.5% of the time with an initial input of 3.97 x 109 CFU/ml. E. aerogenes (initial
input, 2.15 x 108 CFU/ml), E. coli (initial input, 4.46 x 108 CFU/ml), E. faecalis (initial input,
1.75 x 109 CFU/ml), L. monocytogenes (initial input, 2.60 x 109 CFU/ml), and S. pyogenes
(initial input, 5.60 x 108 CFU/ml) all identified as Staphylococcus species via laser-light
scattering 0.00% of the time. Statistical significance (P-value) was determined by comparing
results of each negative control strain to S. aureus. One asterisk (*) denotes a P-value less
than 0.001.
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Figure 30. Percent identified as Staphylococcus species from mixed samples. S. aureus
identified as Staphylococcus species via laser-light scattering 80% of the time with an initial
input of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes (initial input, 2.15 x 108 CFU/ml)
identified as Staphylococcus species via laser-light scattering 50% of the time. S. aureus + E.
coli (initial input, 4.46 x 108 CFU/ml) identified 0% of the time. S. aureus + E. faecalis
(initial input, 1.75 x 109 CFU/ml) identified 50% of the time. S. aureus + L. monocytogenes
(initial input, 2.60 x 109 CFU/ml) identified 60% of the time. S. aureus + M. luteus (initial
input 3.98 x 109 CFU/ml) identified 75% of the time. S. aureus + S. pyogenes (initial input,
5.60 x 108 CFU/ml) identified 75% of the time. S. aureus + S. pyogenes + M. luteus identified
75% of the time. S. aureus + S. pyogenes + E. coli identified 0% of the time. Statistical
significance (P-value) was determined by comparing results of each negative control strain to
S. aureus. One asterisk (*) denotes a P-value less than 0.05.
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Figure 31. Percent identified as Staphylococcus species from mixed specimens by dilution.
After IMS capture and bacterial enrichment, samples underwent laser-light scattering
identification. Percent identified as Staphylococcus species was determined for each set of
samples. Bar colors represent different concentrations of initial input of S. aureus to samples.
Estimated equal concentrations of S. aureus and negative control strains were added to each
sample. Statistical analysis was conducted by one-way ANOVA Bonferroni multiple
comparison test, *denotes P < 0.01 and **denotes P < 0.001. Each dilution by bacteria was
compared to each other for statistical analysis, interspecies comparison was not conducted.
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Analysis of rapid laser-light scattering detection from IMS swab samples
In clinical settings, specimen collection on swabs is one of the most utilized form
of specimen collection for infections of skin and soft tissues. In order to determine if S.
aureus could be identified from swab specimen collection, pre-established IMS and laserlight scattering identification methods were utilized and evaluated for accuracy of
identification. Upon the establishment of IMS, enrichment, and laser-light scattering
identification methods from swab samples, identification of S. aureus was then evaluated
in both swab pure samples and swab mixed samples (Figures 32 and 33). Percent
identified as Staphylococcus species from pure swab samples displayed that S. aureus
identified as Staphylococcus species via laser-light scattering 82% of the time with an
average initial input of 1.12 x 108 CFU/ml. S. pyogenes misidentified as Staphylococcus
species via laser-light scattering 10% of the time with an initial input of 2.22 x 107
CFU/ml. E. aerogenes with an average initial input of 2.77 x 108 CFU/ml, E. coli with an
average initial input of 6.19 x 106 CFU/ml, E. faecalis with an average initial input of
3.49 x 108 CFU/ml, L. monocytogenes with an average initial input of 1.75 x 108 CFU/ml,
M. luteus with an average initial input of 7.35 x 107 CFU/ml, human nose swab with an
average initial input of 3.00 x 108 CFU/ml, direct human nose swab with an average
initial input of 1.82 x 105 CFU/ml, human skin swab with an average initial input of 4.05
x 108 CFU/ml all identified as Staphylococcus species via laser-light scattering 0.00% of
the time. Statistical significance (P-value) was determined by comparing results of each
negative control strain to S. aureus via one-way ANOVA Bonferroni multiple
comparison test. Statistical significance, P-value less than 0.001 was present for all
negative controls when compared to S. aureus (Figure 32). Figure 31 displays how the
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percent identified as Staphylococcus species differed by each dilution for the averages
displayed in Figure 30.
By generating mixed, multi-microbial samples, we were able to evaluate the
accuracy of our methods for S. aureus capture and identification when challenged with
multiple species of bacteria in a sample. Evaluation of S. aureus capture and
identification from multi-microbial samples gave a more realistic analysis of S. aureus
capture from clinical swab samples. In order to evaluate mixed swab specimens, percent
identified as Staphylococcus species from mixed swab samples was recorded and
statistical significance was determined by one-way ANOVA Bonferroni multiple
comparison test. S. aureus identified as Staphylococcus species via laser-light scattering
83% of the time with an initial input of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes
with an initial input of 2.77 x 108 CFU/ml identified as Staphylococcus species via laserlight scattering 78% of the time. S. aureus + E. coli with an initial input of 6.19 x 106
CFU/ml identified 29% of the time. S. aureus + E. faecalis with an initial input of 3.49 x
108 CFU/ml identified 29% of the time. S. aureus + L. monocytogenes with an initial
input of 1.75 x 108 CFU/ml identified 57% of the time. S. aureus + M. luteus with an
initial input of 7.35 x 107 CFU/ml identified 71% of the time. S. aureus + S. pyogenes
with an initial input of 2.22 x 107 CFU/ml identified 71% of the time. S. aureus + a
human nose swab with an initial input of 3.00 x 108 CFU/ml identified 75% of the time.
S. aureus + a human skin swab with an initial input of 4.05 x 108 CFU/ml identified 75%
of the time. S. aureus + a human nose swab + and a human skin swab identified 70% of
the time. S. aureus + S. pyogenes + M. luteus identified 43% of the time. S. aureus + S.
pyogenes + E. coli identified 0% of the time. Statistical significance (P-value) was
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determined by comparing results of each negative control strain to S. aureus. Statistical
significance was found with a P-value less than 0.01 when S. aureus + S. pyogenes + E.
coli was compared to S. aureus alone (Figure 33). Figure 34 displays how the percent
identified as Staphylococcus species differed by each dilution for the averages displayed
in Figure 33.
The average growth (CFU/ml) by enrichment over a 5 hour time frame from swab
specimen collection was determined in order to quantify the number of progeny produced
during the enrichment step. To calculate this, after IMS capture, the S. aureus cells
captured by anti-Protein A DynaBeads were resuspended in filtered TSB agar and
incubated at 37 ͦ C for 5 hours while shaken at 250 rpm. Each hour, the tubes were
magnetically separated for 3 minutes and the supernatant was spread plated on TSB agar
and incubated at 37 ͦ C for 18 hours. Colony forming units were then calculated. At hour 0
of enrichment, average growth was 4.73 x 107 CFU/ml, after 1 hour of enrichment
average growth was 2.19 x 108 CFU/ml, after 2 hours of enrichment average growth was
4.57 x 108 CFU/ml, after 3 hours of enrichment average growth was 2.66 x 109 CFU/ml,
after 4 hours of enrichment average growth was 4.36 x 109 CFU/ml, and after 5 hours of
enrichment average growth was 1.27 x 1010 CFU/ml (Figure 36).
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Figure 32. Percent identified as Staphylococcus species from pure swab samples. S. aureus
identified as Staphylococcus species via laser-light scattering 82% of the time with an initial
input of 1.12 x 108 CFU/ml. S. pyogenes identified as Staphylococcus species via laser-light
scattering 10% of the time with an initial input of 2.22 x 107 CFU/ml. E. aerogenes (initial
input, 2.77 x 108 CFU/ml), E. coli (initial input, 6.19 x 106 CFU/ml), E. faecalis (initial input,
3.49 x 108 CFU/ml), L. monocytogenes (initial input, 1.75 x 108 CFU/ml), M. luteus (initial
input, 7.35 x 107 CFU/ml), human nose swab (initial input, 3.00 x 108 CFU/ml), direct human
nose swab (initial input, 1.82 x 105 CFU/ml), human skin swab (initial input, 4.05 x 108
CFU/ml) all identified as Staphylococcus species via laser-light scattering 0.00% of the time.
Statistical significance (P-value) was determined by comparing results of each negative
control strain to S. aureus. One asterisk (*) denotes a P-value less than 0.001.
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Figure 33. Percent identified as Staphylococcus species from mixed swab samples. S. aureus
identified as Staphylococcus species via laser-light scattering 83% of the time with an initial
input of 4.86 x 109 CFU/ml. S. aureus + E. aerogenes (initial input, 2.77 x 108 CFU/ml)
identified as Staphylococcus species via laser-light scattering 78% of the time. S. aureus + E.
coli (initial input, 6.19 x 106 CFU/ml) identified 29% of the time. S. aureus + E. faecalis
(initial input, 3.49 x 108 CFU/ml) identified 29% of the time. S. aureus + L. monocytogenes
(initial input, 1.75 x 108 CFU/ml) identified 57% of the time. S. aureus + M. luteus (initial
input 7.35 x 107 CFU/ml) identified 71% of the time. S. aureus + S. pyogenes (initial input,
2.22 x 107 CFU/ml) identified 71% of the time. S. aureus + Nose (initial input, 3.00 x 108
CFU/ml) identified 75% of the time. S. aureus + Skin swab (initial input, 4.05 x 108 CFU/ml)
identified 75% of the time. S. aureus + Nose + Skin identified 70% of the time. S. aureus + S.
pyogenes + M. luteus identified 43% of the time. S. aureus + S. pyogenes + E. coli identified
0% of the time. Statistical significance (P-value) was determined by comparing results of each
negative control strain to S. aureus. One asterisk (*) denotes a P-value less than 0.01.
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Figure 34. Percent identified as Staphylococcus species from mixed swab specimens by
dilution. Percent identified as Staphylococcus species was determined for each set of swab
samples. Bar colors represent different concentrations of initial input of S. aureus to samples.
Estimated equal concentrations of S. aureus and negative control strains were added to each
sample. Statistical analysis was conducted by one-way ANOVA Bonferroni multiple
comparison test, **denotes P < 0.01 and *denotes P < 0.001. Each dilution by bacteria was
compared to each other for statistical analysis, interspecies comparison was not conducted.
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Figure 35. Percent identified as Staphylococcus species from whole milk samples. After IMS
capture and bacterial enrichment, samples underwent laser-light scattering identification.
Percent identified as Staphylococcus species was determined for each set of samples. Samples
were 10-fold serial diluted from an overnight of S. aureus or B. subtilis, Sa-1 represents the 102
S. aureus serial dilution (initial input 2282000 CFUs), Sa-2 represents the 10-3 S. aureus serial
dilution (initial input 228200 CFUs), Sa-3 represents the 10-4 S. aureus serial dilution (initial
input 22820 CFUs), Sa-4 represents the 10-5 S. aureus serial dilution (initial input 2282 CFUs),
Sa-5 represents the 10-6 S. aureus serial dilution (initial input 275 CFUs), Sa-6 represents the
10-7 S. aureus serial dilution (initial input 27 CFUs), and Bs represents the 10-2 B. subtilis serial
dilution (initial input 1800000 CFUs). S. aureus identified as Staphylococcus species in 100%
of samples when the initial input of bacteria exceeded 275 CFUs. When the initial input of S.
aureus was less than 275 (Sa-6), the sample identified as Staphylococcus species 0% of the
time. Negative control, B. subtilis identified as Staphylococcus species at a rate of 0%
indicating no non-specific binding during IMS methods. Statistical analysis was not conducted
due to low sample size.
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Figure 36. Average growth (CFU/ml) of S. aureus by enrichment from swab specimen
collection over 5 hours. After IMS capture, S. aureus captured by anti-Protein A DynaBeads
were resuspended in filtered TSB agar and incubated at 37 ͦ C for 5 hours while shaken at 250
rpm. Each hour, the tubes were magnetically separated for 3 minutes and the supernatant was
spread plated on TSB agar and incubated at 37 ͦ C for 18 hours. Colony forming units were
then calculated. At hour 0 of enrichment, average growth was 4.73 x 107 CFU/ml, after 1 hour
of enrichment average growth was 2.19 x 108 CFU/ml, after 2 hours of enrichment average
growth was 4.57 x 108 CFU/ml, after 3 hours of enrichment average growth was 2.66 x 109
CFU/ml, after 4 hours of enrichment average growth was 4.36 x 109 CFU/ml, and after 5
hours of enrichment average growth was 1.27 x 1010 CFU/ml.
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DISCUSSION

IMS capture, enrichment, and laser-light scattering identification method
development
After establishing the methods for rapid S. aureus capture via IMS, we needed to
combine IMS and laser-light scattering technology in order to rapidly identify S. aureus.
Previous studies suggest that faster pathogen identification leads to faster administration
of appropriate treatments, and this has been linked to improved patient outcomes.
Improved patient outcomes include a reduction in hospitalization time, decreased risk of
nosocomial infections, and decreased in medical costs 44. After establishing anti-Protein
A DynaBead IMS capture methods for S. aureus, we developed an enrichment step which
was performed in order to obtain the proper concentration of bacteria for laser-light
scattering identification (1,000 bacteria cells per milliliter) 37. The following conditions
were altered in order to determine optimal conditions for the highest percent identified as
Staphylococcus species for S. aureus: media type for enrichment, filtration of media for
enrichment, removal of beads during enrichment, time of enrichment, removal of media
after enrichment, and resuspension of captured bacteria in filtered water.
The first attempt at combining IMS, enrichment, and laser-light scattering
technology, the following methods were utilized: samples were bound by anti-Protein A
DynaBeads in filtered TSB media at 22 ͦ C, 1-3 hours of enrichment in filtered TSB at 37 ͦ
C, and magnetic separation of anti-Protein A DynaBeads and direct addition of
supernatant to MIT vials for laser-light scattering analysis. These variables resulted in S.
aureus identifying as Staphylococcus species in 30% of samples. In the search to further
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enhance the rate of S. aureus capture, we found that previous studies had established a
link between Protein A expression and growth dependence. Previous studies have
determined that Protein A is expressed on the surface of nearly all S. aureus strains and
occupies approximately 7% of the S. aureus cell surface and that it is upregulated during
the exponential growth phase 30,59. We then sought to determine if increasing the
temperature from 22 ͦ C to 37 ͦ C during the binding procedure between anti-Protein A
DynaBeads and S. aureus cells would affect the overall capture rate of S. aureus. We
hypothesized that increasing the binding temperature from 22 ͦ C to 37 ͦ C would lead to an
upregulation in Protein A on the surface of S. aureus cells present in the sample. The
upregulation of Protein A would then lead to an increased capture rate of S. aureus by
anti-Protein A antibodies, ultimately leading to a higher concentration of S. aureus for
laser-light scattering identification. After subsequent testing, we determined that
incubation during anti-Protein A DynaBead binding at 37 ͦ C resulted in S. aureus
identifying as Staphylococcus species in 36% of samples compared to the 30% without
incubation.
To further develop our methods, it has been suggested from previous studies that
shaking liquid cultures of bacteria helps increase the rate of growth within that sample 38.
Shaking allows the culture to remain aerated and this provides adequate oxygen for the
bacteria within the sample, thus increasing the rate of bacterial growth 38. Knowing this,
we used previously mentioned methods and combined them with agitation. We used two
different agitation speeds, 215 rpm and 250 rpm, to determine if the addition of agitation
would enhance the rate of S. aureus growth during the enrichment step. When samples
were shaken at 215 rpm this resulted in S. aureus identifying as Staphylococcus species
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in 45% of samples. When samples were shaken at 250 rpm this resulted in S. aureus
identifying as Staphylococcus species in 44% of samples.
In order to increase the percentage of S. aureus identifying as Staphylococcus
species using laser-light scatter, we hypothesized that removing the anti-Protein A
DynaBeads after hours 1 or 2 of enrichment would aid in accurate laser-light scattering
identification. Removing the anti-Protein A DynaBeads would potentially result in an
increase in accurate identification by preventing anti-Protein A DynaBeads from entering
the MIT sample. If both S. aureus cells and anti-Protein A DynaBeads were added to a
MIT sample, the laser-light scattering pattern could be altered and identification accuracy
would decrease. These methods included: IMS methods performed in filtered TSB media
at 37 ͦ C, 1-2 hours of enrichment in filtered TSB while shaken at 250 rpm at 37 ͦ C, after
1-2 hours of enrichment, anti-Protein A DynaBeads were removed and the enrichment
incubation of samples resumed, magnetic separation of anti-Protein A DynaBeads and
direct addition of supernatant to MIT vials for laser-light scattering analysis. Although
the DynaBeads were removed, each sample was still magnetically separated for 3
minutes after enrichment in order to reduce the risk of including DynaBeads into a
sample. When anti-Protein A DynaBeads were removed after 1-2 hours of enrichment, S.
aureus identified as Staphylococcus species in 64% of samples.
In order to determine if we could increase the rate of S. aureus growth during the
enrichment step, filtered terrific broth was utilized instead of filtered TSB media. Terrific
broth is a highly enrichment media that is generally used to increase the yield of plasmid
DNA from transformed microbial strains 19. The following protocol was utilized to
compare the efficiency of Terrific broth with TSB: IMS methods performed in filtered
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Terrific broth media at 37 ͦ C, 1-3 hours of enrichment in filtered TSB while shaken at
250 rpm at 37 ͦ C, after 1-2 hours of enrichment, anti-Protein A DynaBeads were removed
and the enrichment incubation of samples resumed, magnetic separation of anti-Protein A
DynaBeads and direct addition of supernatant to MIT vials for laser-light scattering
analysis. When IMS and laser-light scattering identification methods were performed in
filtered Terrific Broth, rather than filtered TSB, S. aureus identified as Staphylococcus
species in 50% of samples. Due to the reduced percent identification of S. aureus when
enriched in Terrific Both, we decided to utilized TSB media in future experiments.
After altering variables to increase the accuracy of laser-light scattering
identifications of S. aureus, we wanted to determine if removing the anti-Protein A
DynaBeads and TSB enrichment media would increase the accuracy of identification.
Knowing the importance of particulates within a MIT sample in laser-light scattering
patterns, we hypothesized that removing potential laser-light scattering pattern
particulates could help to increase the rate of S. aureus identification. After altering the
above variables for IMS capture, enrichment, and laser-light scattering identification, the
following methods were established as the optimal conditions: IMS methods performed
in filtered TSB media at 37 ͦ C, 1-5 hours of enrichment in filtered TSB while shaken at
250 rpm at 37 ͦ C, after enrichment anti-Protein A DynaBeads were removed and so was
the TSB media (by pelleting the cells in the supernatant), S. aureus cells were then
resuspended in 10-50 µl of filtered water, vortexed (to break up the bacteria pellet and
resuspend the bacterial cells) and samples were then added to MIT vials for laser-light
scattering analysis. When these conditions were utilized, S. aureus identified as
Staphylococcus species in 80% of samples (Figure 28). It is worth noting that all sample
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concentrations (10-2 to 10-6) were included in the average percent identified as
Staphylococcus species. Samples that were more highly concentrated with S. aureus had
higher percent identifications as Staphylococcus species.
IMS capture, enrichment, and laser-light scattering identification
After establishing anti-Protein A DynaBead capture, enrichment, and identification,
the efficiency of the established rapid identification methods were assessed. The ability to
capture, enrich, and identify S. aureus was tested on both S. aureus and the negative
control strains (S. pyogenes, M. luteus, E. faecalis, L. monocytogenes, E. aerogenes, and
E. coli) in order to evaluate its specificity for S. aureus alone. S. aureus was then mixed
with negative controls to create a more complex and realistic specimen sample, the
efficiency of the rapid identification methods was then assessed. For each sample that
was tested, the average initial input (CFU/ml) of bacteria were determined.
When IMS capture, enrichment, and single laser-light scattering identification
methods were performed S. aureus identified as Staphylococcus species via laser-light
scattering 80% (Figure 29). M. luteus miss-identified as Staphylococcus species via laserlight scattering 12.5% of the time. E. aerogenes, E. coli, E. faecalis, L. monocytogenes,
and S. pyogenes all identified as Staphylococcus species via laser-light scattering 0.00%
of the time. When comparing S. aureus percent identified as Staphylococcus species
individually to all negative controls via one-way ANOVA Bonferroni multiple
comparison tests, statistical significance was found for each negative control, P-value less
than 0.001. The only negative control that miss-identified as Staphylococcus species was
M. luteus. Reasoning for miss-identification could be due to the fact that M. luteus cell
characteristics closely resemble S. aureus cells. M. luteus cells are Gram-positive cocci
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that are approximately 0.5-3.5 µm in diameter and usually arrange in tetrads or irregular
clusters and S. aureus cells are gram positive cocci that are approximately 0.6 µm in
diameter and usually arrange in clusters 4,83. If the M. luteus cells had grown closer to 0.6
µm in diameter, this could explain why M. luteus identified as Staphylococcus species
using laser-light scattering. MIT is currently working on developing a Staphylococcus
aureus identifier, which could help increase the accuracy for S. aureus identification and
reduce miss-identifications of samples that may closely resemble S. aureus cell
characteristics, like M. luteus. Although M. luteus miss-identified as Staphylococcus
species 12.5% of the time, we hope that our IMS capture and washing methods could
help remove these unbound or non-specifically bound cells in future experiments.
In order to increase the complexity of our laboratory made samples, S. aureus was
combined with negative control strains and IMS capture, enrichment, and laser-light
scattering methods were utilized in order to assess the efficiency of our methods for S.
aureus isolation from mixed samples. All of the polymicrobial results (Figure 30) were
then compared to the results of S. aureus alone (Figure 29). S. aureus identified as
Staphylococcus species via laser-light scattering 80% of the time. When S. aureus was
combined with E. aerogenes, it was identified as Staphylococcus species via laser-light
scattering 50% of the time. When S. aureus was combined with E. coli, S. aureus was
identified as Staphylococcus species 0% of the time. When S. aureus was combined with
E. faecalis, S. aureus identified as Staphylococcus species 50% of the time. When S.
aureus was combined with L. monocytogenes, S. aureus was identified as Staphylococcus
species 60% of the time. When S. aureus was combined with M. luteus, S. aureus was
identified as Staphylococcus species 75% of the time. When S. aureus was combined
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with S. pyogenes, S. aureus was identified as Staphylococcus species identified 75% of
the time. In order to generate further complex samples, S. aureus was combined with two
negative control strains. When S. aureus was combined with S. pyogenes and M. luteus,
S. aureus identified as Staphylococcus species 75% of the time. When S. aureus was
combined with S. pyogenes and E.coli, S. aureus identified as Staphylococcus species 0%
of the time. Statistical significance (P-value < 0.05) was shown when samples containing
E. coli were compared to S. aureus.
After analyzing IMS capture, enrichment, and laser-light scattering methods in
polymicrobial cultures, we determined that when S. aureus was combined with skin
associated microbes, M. luteus and S. pyogenes, S. aureus was identified as
Staphylococcus species 75% of the time, compared to 80% when samples contained S.
aureus alone. However, when S. aureus was combined with E. aerogenes, E. faecalis, L.
monocytogenes displayed a reduction in percent identified as Staphylococcus species,
ranging from 50-60% identified as Staphylococcus species. Although there was a
reduction in percent identified as Staphylococcus species when S. aureus was combined
with these strains, there was no statistical significance to the reduction (P > 0.05). When
S. aureus was combined with E. coli, this combination resulted, with statistical
significance (P < 0.05), in a 0% identification rate for Staphylococcus species.
In typical wound infections, specimens are collected from these types of infection
sites on sterile swabs. In order to determine if IMS could successfully capture S. aureus
from a swab sample, sterile swabs were inoculated with a broth culture containing
dilutions of S. aureus. The swabs were transferred to a test tube containing and
previously established capture, enrichment, and identification protocol were used to
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isolate the bacteria from swab specimens. Since S. aureus is not always isolated in pure
culture from the site of infection, we created pure and mixed swab samples to replicate
normal skin microorganisms and IMS capture, enrichment, and laser-light scattering
identification methods were repeated. In addition, we also combined S. aureus with real
human skin and nose swabs in order to increase the complexity of the samples and assess
if our methods could be utilized in complex biological samples. We hypothesize that our
swab methods would produce results similar to those in pure and mixed culture methods
(Figures 29-30); however, the average bacterial input would be reduced.
Our results of pure swab IMS capture, enrichment, and laser-light scattering
identification displayed that S. aureus identified as Staphylococcus species via laser-light
scattering 82% of the time (Figure 32). S. pyogenes identified as Staphylococcus species
via laser-light scattering 10% of the time. E. coli, E. faecalis, L. monocytogenes, M.
luteus, human nose swab, direct human nose swab, human skin swab all identified as
Staphylococcus species via laser-light scattering, with statistical significant (P < 0.001),
0.00% of the time (Figure 32).
In order to increase the complexity of our laboratory made swab samples, S. aureus
was combined with negative control strains and IMS capture, enrichment, and laser-light
scattering methods were utilized in order to assess the efficiency of our methods for S.
aureus isolation from mixed samples. All of the polymicrobial results (Figure 32) were
then compared to the results of S. aureus alone (Figure 30). Overall, these results
displayed similar results to pure and mixed samples (Figures 29 and 30) and E. coli once
again displayed a significant reduction in percentage identified as Staphylococcus
species.
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In both the pure and swab specimen samples, E. coli contributed to a reduction in
S. aureus identification when mixed with S. aureus. E. coli have multiple virulence
factors that contribute to its pathogenicity, one of those virulence factors is the fimbriae
41

. The fimbriae, or pili, are involved in adhesion/adherence of E. coli to epithelial cells

within its host 29,64. Adherence fimbriae are also involved in biofilm formation within the
epithelial intestinal cells 41. Previous studies have suggested that temperature regulation
may play a role in the upregulation of fimbriae related genes, thus increasing the presence
of this adhesion protein on the surface of E. coli 78.
When conducting initial anti-Protein A DynaBead specificity for S. aureus, E. coli
was utilized as one of the negative control strains. It was determined that E. coli, much
like the other controls strains, had a capture efficiency of less than 1.00% (Figures 2933). However, when developing IMS capture, enrichment, and laser-light scattering
methods we adjusted the binding temperature from 22 ͦ C to 37 ͦ C. This temperature
change was conducted in order to increase the rate of S. aureus capture by upregulating
Protein A on the surface of S. aureus and increase the replication rate of S. aureus. The
known temperature regulation of both Protein A and E. coli fimbriae may result in
enhanced binding competition. Although we determined that anti-Protein A DynaBeads
have specificity for S. aureus when bound at 22 ͦ C in pure culture, we speculate that
increasing the binding temperature could potentially lead to an upregulation in fimbriae.
The primary function of fimbriae is adhesion and its binding has been found to be nonspecific host tissues, via electrostatic hydrophobic/hydrophilic interactions 20. In addition
to non-specific binding to host tissues, fimbriae can interact with inanimate objects and
can often bind fimbriae to fimbriae creating biofilms 20,41,67. We hypothesize that E. coli
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could have been incorporated in the MIT samples even after the washing step. If E. coli
was incorporated into the samples undergoing the enrichment step, both S. aureus and E.
coli growth would occur, resulting in a highly concentrated mixed sample that would not
identify as S. aureus.
The final goal of this section was to quantify the average amount of bacterial
growth each hour (1-5 hours) during the enrichment step. Figure 36 displays the results
recorded from this experiment. On average, after 1 hour of enrichment average growth
was 2.19 x 108 CFU/ml, after 2 hours of enrichment average growth was 4.57 x 108
CFU/ml, after 3 hours of enrichment average growth was 2.66 x 109 CFU/ml, after 4
hours of enrichment average growth was 4.36 x 109 CFU/ml, and after 5 hours of
enrichment average growth was 1.27 x 1010 CFU/ml. By using the average S. aureus
bacterial input (CFU/ml), we were able to determine the necessary time of enrichment
needed to produce the appropriate concentration of bacteria for a positive identification
using laser-light scattering technology. Using the trend line produced in Figure 36 (y =
6E+07e1.1059x) we determined that with the average S. aureus input (4.86 x 109 CFU/ml)
via swab specimen collection, 3.36 hours of enrichment was needed to produce a positive
identification using laser-light scattering technology.
Future directions
In the future, we hope to increase the rate of S. aureus identification above 95%
for both pure and mixed cultures and adjust the IMS washing methods to limit nonspecific binding of pileated bacteria (E. coli and E. aerogenes). In order to increase the
rate of S. aureus identification above 95%, we need to reduce non-specific binding. Nonspecific binding could occur on the walls or caps of the tubes as well as, binding to the
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anti-Protein A DynaBeads, which could be addressed by modifying the washing
procedure. By increasing the percentage of Tween included in our PBS wash buffer or
testing other detergents may aid in reducing non-specific binding.
In the future we also plan to perform IMS capture, enrichment, and laser-light
scattering identification on patient swab samples obtained directly from infected wounds
or soft tissue infections. We hope to perform a single blind experiment, similar to the
single blind experiment conducted in chapter two, with the addition of IMS capture and
enrichment directly from patient swab specimens.
Future directions in combination with our collaborator, MIT, include improving
the Staphylococcus species Identifier to specifically identify Staphylococcus aureus.
Currently MIT reports that the S. aureus Identifier is 95% completed. Once the S. aureus
Identifier is complete the S. aureus Identifier will be validated by testing in the Sharp lab.
We have over two dozen different S. aureus isolates in our strain collection to test the
strength of this Identifier. MIT is also making initial light scattering measurement on a
MRSA strains. We purchased two MRSA panels from the American Type Collection that
contains 17 different MRSA strains with different sccMec types. It will be interesting to
determine if MRSA strains have any consistent light scattering pattern differences
compared to methicillin-sensitive S. aureus (MSSA) strains. The mecA gene genomic
insertions that confer methicillin resistance are relatively small, between 2.820-2.903 Mb
nucleotides and the protein content of the MRSA cell is likely very similar to MSSA
strains. It may push the limits of the technology to differentiate MRSA from MSSA. MIT
also plans to automate the methods we have generated. Although this system generates an
identification for S. aureus faster than traditional methods it is still fairly labor intensive.
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Automating this system could decrease sample preparation time and labor efforts.
Overall, this study has generated a novel and rapid method for S. aureus capture and
identification from pure and mixed swab specimens. Further development of these
methods could lead to applications in both clinical and dairy industries for faster S.
aureus identification. By changing the target of the antibody used in our IMS methods,
there is the potential to apply this technology to any bacteria of interest.
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APPENDIX A

LETTER OF SUPPORT FROM UP HEALTH SYSTEMS- MARQUETTE
(FORMERLY MARQUETTE GENERAL) TO USE CLINICAL PATIENT ISOLATES
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